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 Hallmarks of calorie restriction (CR; consuming ~60% of ad libitum, AL, intake) 
include greater whole body insulin sensitivity and insulin-stimulated glucose uptake 
(ISGU) by skeletal muscle.  This thesis aimed to extend knowledge on mechanisms for 
CR-effects on ISGU by elucidating: 1) CR-effects on insulin signaling and muscle ISGU 
in old age, 2) mechanisms for CR-enhanced Akt phosphorylation (pAkt), and 3) in vivo 
signaling and ISGU in multiple muscles of varying fiber types.  The results demonstrated 
that 24-month-old CR versus AL rats had greater ISGU in isolated epitrochlearis and 
soleus muscles with greater pAkt and phosphorylation of Akt-substrate filamin C, but not 
greater phosphorylation of Akt-substrates AS160 or TBC1D1 or insulin receptor tyrosine 
phosphorylation.   Greater pAkt in isolated soleus from 9-month-old CR versus AL rats 
was not attributable to greater activation of signaling steps proximal to Akt (insulin 
receptor phosphorylation, insulin receptor substrate-1 tyrosine phosphorylation or greater 
insulin receptor substrate-1-phosphatidylinositol-3-kinase activity at 5, 15 or 50 minutes 
insulin exposure).  Analysis of six muscles from 9-month-old rats with in vivo insulin 
exposure revealed that CR versus AL rats had greater pAkt in each of four predominantly 
Type II muscles (epitrochlearis, gastrocnemius, tibialis anterior and plantaris) and one of 
two predominantly Type I muscles (soleus, but not adductor longus) with greater ISGU 
for three of four predominantly Type II muscles (not plantaris) and neither predominantly 
Type I muscle and no diet-effect on insulin receptor tyrosine phosphorylation for any  
xv 
 
muscle.   In conclusion:  1) the CR-related increase in insulin-stimulated pAkt regardless 
of age or experimental model (in vivo or ex vivo) in multiple muscles suggests that Akt  
may be necessary, but not sufficient for a CR-related increase in muscle ISGU; 2) greater 
pAkt for CR versus AL rats was not attributable to detectable diet-related differences in 
insulin signaling steps proximal to Akt suggesting CR-effects on pAkt may rely on other 
mechanisms such as modulation by regulatory proteins that bind to Akt; and 3) the 
similarity for CR-related effects on ex vivo and in vivo ISGU for the epitrochlearis, but 










Insulin resistance is a condition in which a physiological amount of insulin leads 
to subnormal glucose disposal into insulin target tissues and inadequate suppression of 
hepatic glucose production.  It is a primary defect in type 2 diabetes (T2DM) and is also 
an independent risk factor for several chronic diseases that increase in prevalence with 
advancing age (1).  In particular, skeletal muscle can clear as much as 85% of the blood 
glucose load, therefore is a very significant peripheral tissue for preventing the 
accumulation of glucose into the blood (2). It would be tremendously valuable to 
elucidate the mechanisms of insulin stimulated glucose transport and to develop 
meaningful therapies that may serve as interventions that increase insulin sensitivity 
particularly in aging models. 
Calorie restriction without malnutrition (CR; consuming ~60 to 75% of ad libitum 
food intake) is characterized by multiple adaptations that can lead to improved function 
and health in many species.  One of the hallmarks of CR is improved insulin sensitivity 
which is largely secondary to increased insulin-stimulated glucose uptake by skeletal 
muscle.  The greater glucose uptake by insulin-stimulated muscle is attributable to greater 
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recruitment of GLUT4 to cell surface membranes (3).  Many studies have found that CR 
does not elevate skeletal muscle GLUT4 protein abundance,  which suggests that  the CR 
effect on glucose transport depends on improved function of insulin signaling and/or 
GLUT4 vesicle trafficking proteins (4-7).  Insulin binds to its receptor to stimulate 
tyrosine autophosphorylation to phosphorylate insulin receptor substrates (IRS).  IRS1 is 
the predominant isoform in skeletal muscle, and tyrosine phosphorylated-IRS1 binds 
phosphatidylinositol 3-kinase (PI3K), which is essential for insulin to induce GLUT4 
translocation.  A key post-PI3K activator of insulin-stimulated glucose transport is the 
Ser/Thr kinase known as Akt.  A consistent effect of CR is a substantial increase in the 
insulin-stimulated Akt phosphorylation, on two important sites (Thr308 and Ser473) 
important for insulin mediated glucose uptake (8-13).   Mammals express three Akt 
isoforms that have distinct, but overlapping functions, and Akt1 and Akt2 are abundantly 
expressed by skeletal muscle.   Akt2 has been identified as the isoform that is crucial for 
insulin-mediated GLUT4 translocation and glucose uptake (14-17).  Insulin also causes a 
protein named Akt substrate of 160 kDa (AS160) to become phosphorylated on multiple 
Akt-phosphomotifs (18).  Two sites (Thr642 and Ser588) were shown to be crucial for a 
large portion, but not all, of insulin-mediated GLUT4 translocation to cell surface 
membranes (19).  
 This dissertation aimed to extend knowledge on mechanisms for CR-effects on 
insulin-stimulated glucose uptake by elucidating: 1) CR-effects on insulin signaling and 
muscle insulin-stimulated glucose uptake in old age, 2) mechanisms for CR-enhanced 
Akt phosphorylation, and 3) in vivo signaling and insulin-stimulated glucose uptake in 
multiple muscles of varying fiber types. 
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Study 1: Calorie Restriction Enhances Insulin-stimulated Glucose Uptake and Akt 
Phosphorylation in Both Fast-twitch and Slow-twitch Skeletal Muscle of 24 Month-old 
Rats 
Earlier studies have assessed the influence of CR on various aspects of the insulin 
signaling pathway that regulates GLUT4 vesicles in skeletal muscle in adult animals (3, 
8-10, 20-25).  In contrast to the relatively extensive amount of research on the 
mechanisms for the CR-induced elevation in insulin-stimulated glucose uptake in 
muscles from adult animals, little is known about CR effects on insulin signaling in 
muscle from old rats.  A few studies have evaluated the influence of CR on insulin 
receptor function in skeletal muscle of old rats (6, 26, 27), but these studies did not 
determine if there were fiber type differences.  The effects of CR on Akt or AS160 
phosphorylation in insulin-stimulated muscle from old rats, regardless of fiber type, have 
not been reported.  Furthermore, the influence of CR on GLUT4 abundance in the 
epitrochlearis and soleus of old rats is unknown. 
 
Study 2: Comparison of Ad Libitum Fed and Calorie Restricted Rats for the Time 
Course of Insulin’s Activation of Signaling Steps Required for Greater Glucose Transport 
by Isolated Skeletal Muscle  
Most (28-30), but not all (6) of the published studies that have evaluated CR 
effects on skeletal muscle insulin receptor (IR) function at submaximally effective insulin 
levels have not found diet-induced differences.  In a previous study (24), there were no 
significant diet effects on IR tyrosine phosphorylation or IRS1-PI3K activity with a 
physiologic insulin concentration. These results suggest elevation in Akt phosphorylation 
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with CR was not attributable to enhancement in insulin receptor or IRS1-PI3K activity 
(13). The goal of this project is to determine the time course of insulin signaling with CR 
versus. AL in response to a physiological insulin dose and determine if these observations 
may be attributable to reversal of transient CR effect on proximal steps of insulin 
signaling that may have reversed by the time point at which previous studies have 
evaluated insulin signaling (typically after ~50 minutes of insulin exposure). 
 
Study 3: In Vivo Assessment of the Effects of Calorie Restriction on Insulin-stimulated 
Glucose Uptake and the Insulin Signaling Pathway in Multiple Skeletal Muscles 
Compared to the relatively detailed information about CR effects on insulin 
signaling in muscle ex vivo, relatively few studies have focused on insulin signaling in 
rodent muscle of CR rats exposed to insulin in vivo.  A major gap in current knowledge is 
the lack of any published data on the effect of in vivo administration of a physiologic 
insulin dose on insulin signaling in skeletal muscle from CR compared to AL rats. The 
purpose of this study was to evaluate the mechanisms of in vivo insulin-stimulated 
glucose uptake and phosphorylation of key insulin regulated proteins in multiple skeletal 
muscles from adult ad libitum fed and CR (consuming 65% of ad libitum intake) 9mo-old 







REVIEW OF LITERATURE 
 
 
Significance of Calorie Restriction 
Multiple lines of evidence indicate that calorie restriction (CR; consuming ~60-
75% of ad libitum intake) has beneficial effects on health span and extends lifespan 
across various species, including worms, fish, flies, mice, and rats (31-33).  Although 
knowledge of CR effects on lifespan in humans is  not entirely clear due to difficulty in 
conducting the proper scientific studies, there is an on-going 20-year longitudinal study 
on CR effects in non-human primates that demonstrates some important benefits of CR, 
including delayed mortality and reduced incidence of diabetes, cancer, and cardiovascular 
disease (34).    Older rhesus monkeys undergoing long-term CR exhibit benefits on 
skeletal muscle, including attenuation of sarcopenia (35) and increased insulin sensitivity 
(36) thereby delaying common age-related declines in skeletal muscle function and 
insulin resistance.  
Increased insulin sensitivity and reduced plasma insulin levels are hallmarks of 
CR in multiple species including mice (8, 37), rats (24, 38), monkeys (39), and humans 
(40-42).  Insulin resistance is defined as a subnormal response to a normal dose of 
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insulin. It is associated with several other chronic diseases including type 2 diabetes, 
atherosclerosis, hypertension, malignancy, and cognitive dysfunction (2, 43, 44).  Thus, 
CR serves as an intervention that may help alleviate or prevent prevalent age-related 
pathologies associated with insulin resistance.  
 
Significance of Skeletal Muscle Glucose Transport 
Insulin resistance is a precursor for the progression to type 2 diabetes mellitus 
(T2DM).  Twenty years ago T2DM was primarily diagnosed as a disease of adulthood. 
However, with increased incidence, T2DM now is estimated in the world to account for 
as much as 45% of  diabetes diagnosed in children and as much as 95% of all diabetic 
cases in the United States as of 2007 (45, 46).    In 2000, 8.8% of U.S. adults at least 20 
years of age were diagnosed with diabetes and this estimate is expected to rise to 11.2% 
of the population by 2030 (46). The economic burden and health consequences of T2DM 
are therefore expected to increase significantly within the next two decades.  
Glucose transport in skeletal muscle occurs by facilitated diffusion mediated by 
glucose transporter proteins, with the GLUT4 transporter responsible for insulin-
stimulated glucose transport (47-50).  Glucose transport is a rate controlling step for 
glucose metabolism in skeletal muscle cells (51).  Insulin induces increased glucose 
uptake into insulin-sensitive cells (including skeletal muscle and adipocytes), and thus 
regulates blood glucose levels especially after feeding (27).  In particular, skeletal muscle 
can dispose of as much as 85% of insulin-induced clearance of the blood glucose load 
(10).  Chronic hyperglycemia is a diagnostic sign of diabetes mellitus which is the 
leading cause of blindness due to retinopathy, end stage renal disease, and lower 
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extremity amputations.   In addition to hyperglycemia, compensatory hyperinsulinemia 
ensues further contributing to disease (43, 44, 52).  High blood insulin concentrations 
result from the increased production of insulin from the pancreas in an attempt to 
overcome insulin resistance in peripheral tissues, i.e. skeletal muscle. Given that skeletal 
muscle is the tissue that accounts for the greatest amount of whole body glucose disposal 
(2), elucidating interventions that increase insulin-mediated glucose uptake by skeletal 
muscle (38, 53, 54) is critically important in the context of an obesity and the T2DM 
epidemic 
 It has been well-established that insulin stimulates GLUT4 translocation. A 
tremendous amount of research has been performed to elucidate the specific mechanisms 
that regulate insulin-stimulated GLUT4 translocation and glucose transport in skeletal 
muscle with the goal of developing meaningful therapies that may serve as interventions 
for hyperinsulinemia and hyperglycemia.  A full understanding of skeletal muscle 
glucose uptake regulation via the insulin signaling pathway is important to maximize 
targets for interventions that aim to reverse defects in glucose metabolism.  
 
The Insulin Signaling Pathway 
 The insulin receptor is a heterotetrameric protein consisting of two alpha subunits 
and two beta subunits. The alpha subunits are located on the extracellular surface of the 
plasma membrane and contain the insulin binding site. The beta subunits span the plasma 
membrane and are involved with intracellular signaling (55). Insulin action begins by 
binding to the alpha subunit of the insulin receptor on the cell surface (56) and triggers 
autophosphorylation of tyrosine residues on the beta subunit of the insulin receptor (57).  
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Mutations of insulin receptor tyrosine residues 1162 and 1163 reduce insulin-stimulated 
autophosphorylation of the insulin receptor, receptor tyrosine kinase activity and insulin-
stimulated uptake of 2-deoxyglucose (58).  Insulin receptor autophosphorylation enables 
the recruitment and phosphorylation of the intracellular adaptor proteins called insulin 
receptor substrates (IRS).  IRS-1 is the predominant isoform in skeletal muscle, and 
skeletal muscle IRS-1 is important for normal glucose homeostasis (59, 60).  IRS-1 
associates with and activates the phosphoinositol 3 kinase (PI3K) enzyme.  Activated 
PI3K phosphorylates the 3rd position on the inositol ring of phosphoinositides (61) 
catalyzing the formation of phosphatyidyinositol-3,4-biphosphate (PIP2) to  
phosphatidylinositol 3,4,5-triphosphate (PIP3).  PIP3 recruits serine kinases (including 
PDK1 and Akt) to the plasma membrane which are important for insulin transduction 
(62).  
Akt, a serine kinase downstream of the PI3K, regulates many diverse functions in 
the cell including glucose transport, protein synthesis, glycogen synthesis, cellular growth 
and development.  Of the three isoforms of Akt, Akt 1 and Akt 2 are the predominant Akt 
isoforms expressed in skeletal muscle (63-66).  Upstream phosphoinositide-dependent 
kinases-1 (PDK1) and mammalian target of rapamycin complex-2 (mTORC2) activate 
Akt by phosphorylation on T308 and S473 residues, respectively. Through knockout 
mice and cell culture mutation analysis it has been demonstrated that Akt1 is important 
for growth and development while Akt2 is primarily responsible for regulating glucose 
metabolism (67, 68). Further, Ng et al. reported that Akt2 is sufficient to stimulate 
GLUT4 translocation (69).  Akt phosphorylates various protein substrates on serine or 
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threonine residues in the RXXRXXS/T consensus motif (70). Therefore substrates 
containing this motif are candidates that may link Akt to glucose transport. 
A protein named Akt substrate of 160kDa (AS160) was discovered to be insulin 
responsive (18) and involved in GLUT4 translocation (19). AS160 was characterized in 
3T3-L1 adipocytes and, in addition to being insulin responsive, was determined to be 
located downstream of the PI3K-Akt pathway.  It is the most distal insulin signaling 
protein to date that has been clearly linked to GLUT4 translocation.  AS160 contains a 
Rab GTPase activating protein (GAP) domain suggesting a possible role in insulin 
dependent vesicular trafficking (71). It was revealed that AS160 contained 5 potential 
Akt target phosphomotiffs (RXXRXXS/T). Kane et al. (18) demonstrated that AS160 is a 
substrate of Akt by incubating AS160 with recombinant Akt1 in vitro.   To demonstrate 
the link between AS160 and GLUT4 translocation, Sano et al. (19) produced mutations 
on one key Akt phosphomotif (Thr642) on AS160 and found a significant decrease in 
insulin stimulated GLUT4 translocation. Although these initial findings characterized 
AS160’s role as a regulator of insulin-stimulated glucose transport in 3T3-L1 cells, it was 
also recognized that AS160 was expressed by skeletal muscle. Studies by Arias et al. (72) 
and Bruss et al. (73) revealed that insulin increases AS160 phosphorylation in rat skeletal 
muscle. Insulin-stimulated AS160 phosphorylation was eliminated by the PI3K inhibitor 
wortmannin indicating that the increase in AS160 phosphorylation in muscle is PI3K 
dependent. Furthermore, in skeletal muscle from Akt2 knockout mice, an intraperitoneal 
injection of insulin did not increase AS160 phosphorylation suggesting that Akt2 is the 
key isoform that phosphorylates AS160 with insulin stimulation (74). AS160 was also 
shown to be important for glucose uptake in skeletal muscle. Overexpression of AS160 
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that was mutated on 4 key insulin-responsive Akt phosphomotifs (4P mutant) inhibited 
~50% of the insulin-stimulated increase in glucose uptake in skeletal muscle. The results 
in skeletal muscle support the idea that AS160 is essential for the full effect of insulin on 
glucose uptake in skeletal muscle.  
Although AS160-dependent mechanisms are important for a substantial portion of 
insulin-mediated glucose uptake, it is not sufficient for the full effect. TBC1D1 is a 
recently discovered paralog of AS160.   TBC1D1 also has a GAP domain, regulating Rab 
activity, and it can regulate GLUT4 translocation in 3T3- L1 cells. Chen et al.(75) 
demonstrated in a cell free assay that Akt can phosphorylate TBC1D1 on several sites.  
TBC1D1 can also modulate glucose uptake in skeletal muscle.  Therefore, TBC1D1 
could function as an Akt-dependent substrate important for glucose transport regulation 
in skeletal muscle.  
Philip Cohen’s group identified the cytoskeleton protein filamin C (FLNc) as an 
Akt substrate. FLNc was shown to be phosphorylated on S2213 with insulin stimulation 
and this phosphorylation was prevented by the presence of the specific PI 3-kinase 
inhibitor wortmannin in C2C12 myoblasts (76). Filamin C is highly expressed in skeletal 
muscle and is reported to stabilize actin filament networks on cell membranes (77).  
Insulin signaling molecules and translocation of GLUT4 transporter vesicles to the cell 
membrane has been shown to rely on the integrity and maintenance of actin filaments 
(78, 79).  Furthermore, CR increased filamin C phosphorylation in the rat epitrochlearis 




Relationship between Skeletal Muscle Fiber Type and Insulin-Stimulated Glucose 
Transport 
Skeletal muscle is a heterogeneous tissue and specific muscles can vary greatly in 
their fiber type composition. The gold standard method for categorizing fiber types is 
identifying each skeletal muscle fiber by its myosin heavy chain (MHC) expression. In 
adult rat skeletal muscle, type I, IIA, IIB, and IIX are the myosin isoforms expressed.  
This heterogeneity can be accompanied by different metabolic characteristics (i.e. 
insulin-stimulated glucose uptake) for a particular skeletal muscle. Insulin-stimulated 
glucose uptake is regulated by the GLUT4 transporter and GLUT4 abundance has been 
shown to vary within different isolated rat skeletal muscles (80, 81).  When this 
variability was correlated with the fiber type, studies suggest that GLUT4 abundance is 
greater for oxidative (type I) fibers or the fast-oxidative (type IIA) compared to fast-
glycolytic fibers (IIB) (81, 82).  The results from these studies demonstrate the 
importance of considering skeletal muscle fiber type make-up and its capacity for insulin-
stimulated glucose transport. Rat skeletal muscle composed of primarily of type I 
oxidative fibers (soleus) and type IIA fibers (flexor digitorum brevis) were both shown to 
have at least two fold higher insulin stimulated glucose uptake compared to skeletal 
muscle with a greater proportion of fast-glycolytic fibers(80). Furthermore, MacKrell et 
al. (83) studied insulin-stimulated glucose uptake in isolated skeletal muscle single fibers 
from rats and found that fast-oxidative fibers (type IIA) have significantly higher glucose 
uptake rates compared to fast-glycolytic fibers (type IIB).  The data together suggest that 
type I and type IIA fibers have more similar profiles when compared to type IIB and type 
IIX fibers with respect to insulin stimulated glucose transport.  A full understanding of 
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the mechanisms of insulin-stimulated glucose transport in skeletal muscle requires 
knowledge on multiple skeletal muscle tissue as each skeletal muscle is composed of a 
unique metabolic profile based on its own fiber type composition.   
 
Effects of Aging on Skeletal Muscle Insulin Signaling and Glucose Transport  
Identifying defects in skeletal muscle insulin signaling which are responsible for 
the inability of the muscle cell to properly dispose of blood glucose are important in 
understanding both primary and secondary aging as causes of insulin resistance.  There is 
progressive insulin resistance, even in “healthy” individuals who will not progress to the 
development of Type 2 diabetes as they age.  However, very little is understood about the 
specific mechanisms that cause these primary age-related changes in muscle glucose 
metabolism.  Previous studies have revealed a subtle yet significant decrement in glucose 
uptake in both skeletal muscle in vivo and isolated skeletal muscle (84). The euglycemic-
hyperinsulinemic clamp technique is the gold standard for assessing whole body in vivo 
insulin sensitivity. Results from in vivo experiments include the direct influences of 
various factors absent from ex vivo experiments, including:  blood flow, neural inputs, 
blood hormones and cytokines, in addition to the intrinsic characteristic of the muscle.   
Previous studies using this technique assessed whole body insulin resistance and 
observed that old rats (20 to 24 month old rats) compared to adult (6 to 10 month old rats) 
have an age-related insulin resistance in peripheral tissues which includes skeletal 
muscle. The euglycemic-hyperinsulinemic clamp in combination with use of an 
injectable radiolabeled 2DG tracer allows measurement of 2DG uptake in individual 
skeletal muscles.  One study using this procedure found an age-related decrement in 
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insulin sensitivity in the predominantly slow twitch soleus muscle, but not in the 
predominantly fast twitch quadriceps femoris. This result suggests that not all skeletal 
muscles become resistant with age in the face of whole body age-related insulin 
resistance.    In order to  more closely examine this phenomenon intrinsic to the skeletal 
muscle,  Sharma et al.(84) evaluated glucose uptake by both the isolated soleus and 
epitrochlearis muscles from 9 month old and 25 month old rats ex vivo. Advantages of ex 
vivo preparations include more experimental control and measurements are separated 
from sustained systemic effects. In the predominantly slow-twitch soleus muscle there 
was age-related insulin resistance for glucose uptake, however for the predominantly fast-
twitch epitrochlearis insulin stimulated glucose uptake there was not a significant 
difference between the 9 month and 25 month old rats. The extent of age-related 
resistance therefore is not uniform in all muscles. Aging has variable effects on insulin-
stimulated glucose transport within muscles that vary in their metabolic profiles. The 
GLUT4 transporter carries glucose into the muscle cell from the bloodstream in response 
to insulin. Despite the differences in glucose transport with age in skeletal muscle, 
research studies show that there are not differences in total GLUT4 content in adult rats 
versus old rats. Thus age-related insulin resistance on each individual skeletal muscle 
may be explained by an aging effect on the insulin signaling pathway which regulates 
GLUT4 trafficking and/or defects in the GLUT4 trafficking process. 
The study by Sharma et al. was also one of the seminal papers to evaluate age-
related resistance on key insulin signaling proteins in 9 versus 24 month rats. In isolated 
epitrochlearis and soleus muscles that were incubated ex vivo with 1.2 nM (physiologic) 
or 30 nM (supraphysiologic) insulin, insulin signaling (Akt and AS160) was examined in 
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adult versus old rats. In the epitrochelaris, there was no decrease reported in the major 
skeletal muscle isoforms pAkt1 T308 and pAkt2 T308 in the old versus adult group with 
30nM of insulin. There were similarly no age-related changes seen in either of the 
isoforms at the T308 site with 1.2nM of insulin.   At Akt S473 (the other important Akt 
insulin-stimulated phosphorylation site) in the epitrochlearis there were no age related 
changes at basal or physiological insulin, but with a supraphysiological insulin level there 
was an age-related decrement. In the soleus, there was an age related decrement in pAkt2 
T308 at 30nM insulin and a trend to decrease with 1.2nM insulin. In the soleus there was 
a trend (P=0.07) for a decrease in glucose uptake in 24 versus 9 month old rats with 
1.2nM insulin, and a significantly reduced glucose uptake with 30 nM insulin. It seems 
likely that Akt2 is related to the decrease in insulin stimulated glucose uptake with age.  
When the Akt substrate, AS160 was evaluated at the critical T642 site there was no 
apparent age-related decrease in AS160 phosphorylation at any insulin concentration. 
This result seemed to suggest that age-related resistance occurs through an AS160 
independent mechanism through other Akt substrates. However, AS160 is regulated on 
multiple insulin-regulated phosphorylation sites, and it can be regulated by binding to 14-
3-3 proteins.  Therefore AS160 cannot be ruled out completely.  Further studies in aging 
muscle are required to fully elucidate the mechanisms that account for glucose transport 
and insulin signaling particular in the face of primary age-related resistance.  
   




 Calorie restriction is well known to enhance insulin-stimulated glucose transport 
in skeletal muscle. Previous studies have documented the CR effect on insulin stimulated 
glucose uptake in adult rats (3, 10, 21, 25, 85-87) and mice (8, 37) in both epitrochlearis 
and soleus muscles.  In 23 month-old rats, CR was to shown to increase insulin 
stimulated glucose uptake in the epitrochlearis muscle.  Dean et al. (3) demonstrated that 
this effect is attributable to a proportional CR-mediated increase in the cell surface 
GLUT4 at the plasma membrane in rat skeletal muscle.  The effect of CR on insulin-
stimulated glucose transport can occur in the absence of increased total GLUT4 protein 
abundance (88).  These results suggest that the mechanism for the CR effect on skeletal 
muscle glucose transport is related to the specific enhancement of the insulin signaling 
pathway leading to increase GLUT4 recruitment to the plasma membrane.    
A few studies have evaluated the effect of CR on the insulin signaling pathway in 
skeletal muscle, but the mechanisms that account for the CR enhancement of insulin-
stimulated glucose uptake are still not entirely clear.  In adult rodents, most studies that 
have evaluated the insulin receptor activation with physiological doses of insulin do not 
report a CR effect (24, 29). Roughly half of the studies that looked at the insulin receptor 
with a supraphysiological dose of insulin found significant changes with the remaining 
studies not detecting altered insulin receptor function with CR (6, 7, 23, 27, 29, 89, 90). 
In old rats, a few studies have evaluated the effect of CR on insulin receptor function in 
skeletal muscle by using an insulin injection. CR does not seem to alter insulin receptor 




Post-insulin receptor signaling has also been shown to increase in some, but not 
all studies using a supraphysiological dose of insulin (3, 7, 10, 23, 25, 89, 90). With a 
physiological does of insulin several studies do not report a significant  CR versus AL 
change in either IRS-1 associated PI3K signaling or IRS-1 tyrosine phosphorylation in rat 
skeletal muscle (24).  However, other studies have reported that muscles from mice (7) 
and monkeys (6) reported that CR resulted in greater IRS-1-PI3K activity.   Taken 
together, these results suggest that CR may affect the insulin signaling pathway 
downstream of PI3-kinase.  
Akt and atypical PKC are key insulin signaling proteins downstream of PI3 kinase 
that have been implicated in the regulation of insulin stimulated glucose uptake in 
skeletal muscle. Insulin-stimulated aPKC was reduced in skeletal muscle from obese non-
diabetic and diabetic rodent skeletal muscle (91, 92). However, Sharma et al. (24) studied 
aPKC in isolated rat skeletal muscle (epitrochlearis and soleus) from adult rats and found 
that aPKC activity did not differ with CR versus AL.  Insulin-stimulated Akt 
phosphorylation has been the most consistent and striking result with CR versus AL in 
adult rats. In numerous studies Akt phosphorylation increases at two key sites (T308 and 
S473) in skeletal muscle undergoing CR (8-10, 24).   This effect is seen with both 
supraphysiologic and physiological levels of insulin. Cho et al. (68) showed that Akt2 is 
the critical isoform for regulating most of the insulin-stimulated glucose transport in 
skeletal muscle. McCurdy et al. (9) revealed that Akt2 at both T308 and S473 were 
increased for CR versus. AL with rodent skeletal muscle stimulated with a submaximally 
effective level of insulin. The effects of CR on Akt phosphorylation in insulin-stimulated 
muscle in old rats in not known.  These previous reports have demonstrated that Akt is 
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likely important for the CR enhanced insulin-mediated GLUT4 translocation and glucose 
uptake in skeletal muscle.   However, further studies elucidating the specific Akt 
substrates that link Akt signaling to the greater insulin-induced GLUT4 translocation and 
glucose transport in response to CR are important. 
CR has been shown to increase insulin-stimulated phosphorylation of AS160 in 
skeletal muscle in adult rats. Sharma et al. (24) evaluated AS160 phosphorylation in the 
epitrochlearis and found that AS160 phosphorylation (T642 and S588) was significantly 
greater in the CR than the AL group with a physiological dose of insulin. In the soleus, 
there was no significant dietary effect on AS160 phosphorylation with either a 
physiologic or supraphysiologic insulin concentration. The CR effect on AS160 
phosphorylation in insulin stimulated skeletal muscle from old rats has not been reported.   
 
Role of CR on In Vivo Insulin Signaling and Glucose Transport 
The euglycemic-hyperinsulinemic clamp is considered the gold standard for 
assessing in vivo insulin sensitivity at the whole body level. In vivo skeletal muscle 
glucose uptake can be specifically evaluated by applying the clamp technique together 
with infusion of radiolabeled 2-deoxyglucose to rodents. There is limited literature 
regarding the effect of CR on insulin signaling and glucose uptake in rodents in skeletal 
muscles in vivo. Wetter et al. (22) utilized an in vivo radioactive 2DG tracer method to 
assess the CR effects on in vivo glucose uptake by various skeletal muscles under 
endogenous insulin levels (i.e., without insulin infusion) in adult rats. Plasma insulin was 
reported to be significantly lower in CR versus AL rats, consistent with increased whole 
body insulin sensitivity. The skeletal muscle of CR versus AL rats had at least equal or 
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higher in vivo glucose uptake values despite having lower insulin levels.  These results 
suggest that CR versus AL enhances in vivo insulin sensitivity and enhances tissue 
specific glucose uptake in skeletal muscle.  In a more recent study, the euglycemic-
hyperinsulinemic clamp was used to study in vivo glucose metabolism with CR in both 
adult and old rats (93). Wistar rats at 8 month and 24 months of age were used to 
determine CR’s effect on in vivo insulin sensitivity in skeletal muscle as function of age.  
With a physiologically-effective dose of insulin it was reported that CR significantly 
increased insulin-stimulated glucose uptake in the soleus and quadriceps at 24 months. At 
8 months of age there was a statistically non-significant trend for increased glucose 
uptake in the soleus with CR, but in the quadriceps there was no observed difference 
between CR versus AL rats. In addition the average insulin level during the clamp 
procedure in the 8 month rats with CR was significantly lower versus AL animals.  
Although there is a large body of evidence of the beneficial effects of CR, little is 
known about the diversity of CR effects in different skeletal muscles.  Therefore, it would 
be valuable to perform an assessment of the effects on insulin signaling and glucose 
uptake with CR in multiple skeletal muscles under controlled physiologic experimental 
conditions.   Apparently no published studies have assessed the influence of long-term 
(several months) of moderate CR on insulin signaling in rat skeletal muscle collected in 
vivo with a physiologic insulin concentration. 
 
Rationale for Models Used in this Research  
Rats were used for the experiments in this dissertation research. Rats are a useful 
model for humans with regard to the influence of age on insulin-stimulated glucose 
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uptake. Like humans, rats have a modest decline in glucose disposal from young to old 
age (~15-35%) (94, 95). Calorie restriction (CR) is used in this thesis as a dietary 
intervention that has been shown to increase insulin sensitivity and therefore is a useful 
model to explore as an intervention to reverse insulin resistance and associated 
pathology.  Past research exploring the CR effects on insulin signaling and glucose 
uptake using rat skeletal muscle has been well established including but not limited to: 
increase cell surface GLUT4 with CR (3), increase glucose uptake with CR (24, 37), 
insulin signaling with CR (6, 9, 10, 23-25, 96). These experiments have contributed to 
our current understanding of CR effects on insulin signaling and glucose uptake but 
future studies are necessary to fully understand the mechanism for CR effects on glucose 
uptake.  Study 1 used 24 month old Fisher Brown Norway (FBN) rats. The 24 month old 
rat is relatively 60 human years (97) and representative of the onset of old age in humans.  
Insulin resistance is more prevalent in old age (98) and knowledge with regard to CR 
effects on skeletal muscle insulin signaling, GLUT4, and glucose uptake in old rats is 
lacking. The FBN strain has been well characterized for aging and calorie restriction 
research from the National Institute of Aging (NIA). Results from Study 1 can also be 
compared to earlier studies that have evaluated the underlying mechanisms for enhanced 
insulin sensitivity in skeletal muscle from adult FBN rats.  
Isolated epitrochlearis and soleus skeletal muscles were used in Study 1 and Study 
2 of this thesis. The epitrochlearis and soleus are examples of skeletal muscles of 
differing fiber types that are widely used in ex vivo incubation experiments. The 
epitrochlearis muscle assists in extension of the forelimb and originates from the tendon 
of the m. lattisimus dorsi and inserts on the medial epicondyle of the humerus (99). The 
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epitrochlearis is 21 to 24 fibers thick (100) which allows for adequate  tissue oxygenation 
to be maintained  and is appropriate for ex vivo muscle incubation for glucose uptake and 
insulin signaling measurements. The predominantly fast-twitch fiber type composition of 
the rat epitrochlearis (75% Type IIb, 17% Type IIa, and 8% Type I) is representative of 
the average fiber type composition of the entire rat hindlimb (76% Type IIb, 19% Type 
IIa, and 5%Type I) (100, 101). The soleus is a postural hindlimb muscle that assists in 
plantarflexion of the foot. The soleus is composed of primarily  slow-twitch Type I fibers 
(0% Type IIb, 12% Type IIa, and 88% Type I) (81) and is also well characterized for ex 
vivo incubations (24, 102, 103).  
The euglycemic-hyperinsulinemic clamp is used in Study 3 of this thesis. This 
method is considered the gold standard for assessing insulin sensitivity and allows for in 
vivo measurements of glucose uptake and insulin signaling. In vivo measurements reflect 
effects of a physiologic milieu by taking into account the intrinsic muscle properties in 
addition to extrinsic factors (i.e. skeletal muscle blood flow, neural inputs, and humoral 
factors). Studies using an in vivo model coupled to an ex vivo model together provides a 
more complete perspective to that of either model in isolation.  
 
Gaps to be Filled by this Research 
The precise cellular mechanism by which CR enhances insulin-mediated cell 
surface GLUT4 translocation in skeletal muscle has not been fully elucidated. The studies 
in this dissertation investigate CR changes in expression and phosphorylation of key 
proteins in the insulin signaling pathway that correspond to an increase in insulin-
stimulated glucose uptake in skeletal muscle. Study 1 assessed the CR effects on insulin 
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signaling and glucose uptake by isolated skeletal muscles (epitrochlearis and soleus) in 
old (24 month-old) rats. CR enhances glucose uptake and Akt phosphorylation in isolated 
epitrochlearis and soleus muscles from adult (9 month-old) rats however AS160 
phosphorylation increased only in the epitrochlearis. We hypothesized that CR would 
enhance glucose uptake and Akt, TBC1D1, and Filamin C phosphorylation in the soleus 
and epitrochlearis muscles from 24 month-old rats, while AS160 phosphorylation would 
increase in the epitrochlearis but not in the soleus.  Study 2 investigated whether the CR 
effect on Akt phosphorylation in isolated soleus muscle from 9 month-old rats is 
attributable to a rapid and transient activation of proximal insulin signaling (pY-IR, pY-
IRS-1, & IRS1-PI3K) in the soleus.  We hypothesized that  phosphorylation of pY-IR, 
pY-IRS-1, and PI3K-IRS-1 would be greater for CR versus AL with insulin stimulation 
at 5 and 15 minutes but not at 50 minutes in the soleus muscle.  Study 3 investigated the 
effects on insulin signaling and glucose uptake in muscles from 9 month-old rats in vivo, 
and explored if the CR effects for epitrochlearis and soleus are similar to other fast-twitch 
(gastrocnemius, plantaris, tibialis anterior) and slow-twitch (adductor longus) muscles. 
We hypothesized that in vivo stimulation of  both predominantly fast-twitch and slow-
twitch muscle of CR versus AL would induce greater glucose uptake and Akt 
phosphorylation while fast twitch muscle of CR versus AL rats would induce greater 
AS160 phosphorylation and slow twitch muscle  from CR versus AL would induce 










Calorie Restriction Enhances Insulin-stimulated Glucose Uptake and Akt 





Calorie restriction (CR) induces enhanced insulin-stimulated glucose uptake 
(ISGU) in fast-twitch (type II) muscle from old rats, but the effect of CR on slow-twitch 
(type I) muscle from old rats is unknown.  The purpose of this study was to assess ISGU 
and phosphorylation of key insulin signaling proteins in isolated epitrochlearis (fast-
twitch) and soleus (slow-twitch) muscles from 24 month-old ad libitum (AL) fed and CR 
(consuming 65% of ad libitum, AL, intake) rats. Muscles were incubated with and 
without 1.2 nM insulin.  CR versus AL rats had greater ISGU, Akt phosphorylation 
(pAkt) on T308 and S473, and filamin C phosphorylation on S2213 for both muscles 
incubated with insulin.  GLUT4 protein abundance and phosphorylation of the insulin 
receptor (Y1162/1163), AS160 (T642 and S588) and TBC1D1 (T596) were unaltered by 
23 
 
CR in both muscles.  These results implicate enhanced pAkt and pfilamin C as potentially 
relevant for the mechanism leading to the CR-induced increase in ISGU by the fast-
twitch epitrochlearis and slow-twitch soleus of old rats.  
 
INTRODUCTION 
Calorie restriction (CR; i.e., consuming ~60-75% of ad libitum, AL, intake) 
without malnutrition leads to improved function and health in many species (104, 105).  
One of the hallmarks of CR is an increase in whole body insulin sensitivity (39-41, 106).  
Given that skeletal muscle accounts for the greatest amount of whole body glucose 
disposal (2), it is not surprising that CR leads to increased insulin-mediated glucose 
uptake by skeletal muscle (38, 53, 54) .   
Because skeletal muscle is a heterogeneous tissue that is composed of type I 
(slow-twitch) and type II (fast-twitch) fibers that differ on the basis of contractile and 
metabolic properties, it is valuable to assess muscles with differing fiber type 
compositions to gain a full understanding of CR effects.  Previous research on adult rats 
or mice has reported that CR leads to greater insulin-stimulated glucose uptake in skeletal 
muscles composed primarily of type I (soleus) or type II (epitrochlearis or extensor 
digitorum longus) fibers (8, 9, 24, 37).  In isolated muscle, CR increases insulin-
stimulated glucose uptake in the primarily type II epitrochlearis muscle of 23 month-old 
rats (4, 21), but there have been no reports on insulin-stimulated uptake in a 
predominantly type I muscle of old rats.    
A number of earlier studies have evaluated the underlying mechanisms for 
improved insulin sensitivity in skeletal muscle from adult rats.  Most of the previous 
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studies have reported little or no CR effect on the abundance of GLUT4 (4, 6, 24, 107), 
the insulin-regulated glucose transporter protein.   We have performed a series of studies 
that characterized the effects of CR on key insulin signaling proteins in skeletal muscle.  
Insulin-induced phosphorylation of Akt is essential for insulin-stimulated glucose uptake 
(68).  In this context, it is significant that the most consistent and substantial increase in 
insulin signaling with CR in skeletal muscle has been an increase in insulin-mediated 
phosphorylation of Akt (3, 8, 9, 23, 25).   Insulin-stimulated Akt phosphorylation was 
increased by CR in both the soleus (composed of ~90% type I fibers) and the 
epitrochlearis (~90% type II fibers) in 9 month-old rats (24).     
In view of the striking CR effect on Akt phosphorylation in adult animals, it is 
clearly relevant to identify the Akt substrate(s) that regulate insulin-stimulated glucose 
uptake.  One link between Akt and glucose uptake was discovered by Sano et al. (18, 19) 
who identified a protein that they called Akt Substrate of 160 kDa (AS160; also known as 
TBC1D4).  They found that AS160 was phosphorylated by Akt in response to insulin, 
and that the phosphorylation of AS160 modulated insulin-stimulated glucose uptake.  
They also convincingly demonstrated that Thr642 and Ser588 of AS160 were the most 
important insulin-regulated Akt phosphosites for insulin-mediated glucose uptake (19).  
Sharma et al. (24) recently reported a muscle-specific effect of CR in 9 month-old rats:  
insulin-stimulated Thr642 and Ser588 phosphorylation of AS160 was increased by CR in 
the epitrochlearis, but not in the soleus. Recently TBC1D1, a paralog of AS160, was 
shown to be phosphorylated on T596 with insulin stimulation and when Thr596 was 
substituted to Ala GLUT4 translocation was decreased in 3T3-L1 adipocytes (108). 
TBC1D1 has also been reported to increase with insulin in rat skeletal muscle (109) 
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however it is not clear whether TBC1D1 is important for the CR effect on insulin-
stimulated glucose uptake in rat skeletal muscle.  Another group identified the 
cytoskeleton protein filamin C (FLNc) as an Akt substrate. FLNc was shown to become 
phosphorylated on S2213 in response to insulin stimulation, and this insulin-induced 
phosphorylation was prevented by the presence of the specific PI 3-kinase inhibitor 
wortmannin in C2C12 myoblasts (76). Filamin C is highly expressed in skeletal muscle 
and is reported to stabilize actin filament networks on cell membranes (77).  Insulin 
signaling molecules and translocation of GLUT4 transporter vesicles to the cell 
membrane have been shown to rely on the integrity and maintenance of actin filaments 
(78, 79).  Furthermore, for CR versus AL rats, filamin C phosphorylation in the 
epitrochlearis muscle stimulated with physiological insulin (Sharma, Arias, Sequea and 
Cartee, unpublished results). 
In contrast to the relatively extensive amount of research on the mechanisms for 
the CR-induced elevation in insulin-stimulated glucose uptake in muscles from adult 
animals, little is known about CR effects on insulin signaling in muscle from old rats.  A 
few studies have evaluated the influence of CR on insulin receptor function in skeletal 
muscle of old rats (6, 26, 27), but these studies did not determine if there were fiber type 
differences.  The effects of CR on Akt, AS160, TBC1D1, or filamin C phosphorylation in 
insulin-stimulated muscle from old rats, regardless of fiber type, have not been reported.  
Furthermore, the influence of CR on GLUT4 abundance in the epitrochlearis and soleus 
of old rats is unknown. 
 The goal of the current study was to begin to fill some of these gaps in knowledge 
with regard to CR effects on skeletal muscle insulin signaling, GLUT4 and glucose 
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transport in old rats.  A novel aspect of the experiment was to assess CR effects on 
insulin-stimulated glucose uptake by both predominantly type I (soleus) and 
predominantly type II (epitrochlearis) skeletal muscles of old rats.  In addition, in the 
same muscles, we probed the influence of CR on the phosphorylation of key insulin 
signaling proteins, including the insulin receptor, Akt, AS160, TBC1D1, and filamin C.  
Finally, we determined if CR resulted in altered expression of GLUT4 protein in the 
soleus and epitrochlearis of old rats.  
 
EXPERIMENTAL PROCEDURES 
Materials. Unless otherwise noted, all chemicals were purchased from Sigma Chemical 
(St. Louis, MO) or Fisher Scientific (Hanover Park, IL).  Human recombinant insulin was 
obtained from Eli Lilly (Indianapolis, IN). Reagents and apparatus for SDS-PAGE and 
immunoblotting were from Bio-Rad Laboratories (Hercules, CA). Anti-phospho-insulin 
receptor Tyr1162/1163 (pIRTyr1162/1163; # 44-504G) and anti-insulin receptor (IR; #AHR0271) 
were from Invitrogen (Camarillo, CA).  Anti-Akt (#9272), anti-phospho AktSer473 
(pAktSer473; #9271), anti-phospho AktThr308 (pAktThr308; #9275), anti-GLUT4 (#2213), and 
anti-rabbit IgG horseradish peroxidase (#7074) were from Cell Signaling Technology 
(Danvers, MA). Anti-phospho-AS160Ser588 (pAS160Ser588; # 3028P2) was from B-
Bridge International (Mountain View, CA).  Anti-phospho-AS160Thr642 (#07-802) and 
anti-AS160 (#07-741) were from Millipore (Billerica, MA). Anti-phospho-filamin CS2213 
(#PB-131) was from Kinasource (Scotland, UK). Anti-filamin C (#SC-48496) was from 
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-TBC1D1T596 was provided 
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by Dr. Makoto Kanzaki (Tohoku University). 2-Deoxy-D-[3H] glucose ([3H]2-DG) and 
[14C]mannitol were from Perkin Elmer (Boston, MA).    
 
Animal Care. Procedures for animal care were approved by the University of Michigan 
Committee on Use and Care of Animals. CR and AL male Fischer 344 × Brown Norway, 
F1 generation rats were obtained at 23 months of age from the National Institute of Aging 
Calorie Restriction Colony and were individually housed for a month prior to 
experimentation.  CR was initiated at 14 weeks of age with 90% of AL, increased to 75% 
of AL at 15 weeks, and to 60% of AL at 16 weeks, a level maintained until 23 months of 
age.   Upon arrival at the Michigan animal facility, rats were housed individually in 
shoebox cages and maintained on a 12:12-h light-dark cycle (lights out at 1700) in 
specific pathogen-free conditions. The AL group had ad libitum access to the NIH31 
chow for the duration of the study. The CR group received NIH31/NIA fortified chow 
(Test Diet), which contains extra vitamin supplementation to provide CR animals with a 
level of vitamins similar to that of animals allowed ad libitum access to the NIH31 diet. 
The CR group received 60-65% of the intake of the AL group daily during the final 
month of the study.  All rats were fed between 1530 and 1630 each day, and food intake 
of both groups was measured daily. All rats were weighed weekly at the same time of 
day. Muscle experiments were performed on AL (N=12 and CR (N=13) fed rats at 24 
months of age. 
Muscle Dissection and Incubation. Food was removed from the cages of all rats on the 
morning of the experimental day between 07:00 and 08:00 h.  Rats were anesthetized 
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with an intraperitoneal injection of sodium pentobarbital (50 mg/kg) between 10:30 and 
13:30 h.  Upon loss of pedal reflexes, soleus and epitrochlearis muscles were removed 
and rapidly rinsed in warm (35oC) Krebs-Henseleit buffer (KHB).  Muscles were 
longitudinally split into strips of similar size for each muscle (2 strips for each 
epitrochlearis, and 4 strips for each soleus).  Muscles strips were subsequently placed in 
vials containing the appropriate media shaking and continuous gassing (95% O2/5% CO2) 
in a heated (35oC) water bath. In the first incubation step, all muscles were incubated in 
vials containing 2 ml KHB supplemented with 0.1% bovine serum albumin (BSA), 2mM 
sodium pyruvate, 6mM mannitol as a rinse step for 30 minutes.   In the second incubation 
step, all muscles were incubated in vials containing 2 ml KHB supplemented with 0.1% 
BSA, 2 mM sodium pyruvate, 6 mM mannitol, and either 0 nM (basal) or 1.2 nM insulin 
for 30 min.  All muscles were then transferred to a third vial containing 2 ml of 
KHB/BSA solution, the same insulin concentration as the previous step, 1 mM 2-DG; 
including a final specific activity of 2.25 mCi/mmol [3H]-2-DG), and 9 mM mannitol 
(including a final specific activity of 0.022 mCi/mmol [14C]-mannitol) for 20 min.  
Following the third incubation step, muscles were rapidly blotted on filter paper 
moistened with ice-cold KHB, trimmed, freeze-clamped using aluminum tongs cooled in 
liquid nitrogen, and stored at -80oC for later processing and analysis. 
 
Muscle Lysate Preparation. Frozen muscles were weighed, transferred to microfuge 
tubes and homogenized in ice-cold lysis buffer (1 ml/muscle) using Qiagen a TissueLyser 
II (Valencia, CA). The lysis buffer contained Tissue Protein Extraction Reagent (Thermo 
Scientific, Rockford, IL; #78510) supplemented with 1 mM EDTA, 1 mM EGTA, 2.5 
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mM sodium pyrophosphate, 1 mM sodium vanadate (Na3VO4),
 1 mM ß-
glycerophosphate, 1 µg/ml leupeptin, and 1 mM phenylmethylsulfonyl fluoride (PMSF).   
Homogenates  were transferred to microfuge tubes, rotated for 1 h at 4°C, and then 
centrifuged (15,000 g) for 15 min (4oC) to remove insoluble material.  Protein 
concentration was measured using the bicinchoninic acid method (Pierce Biotechnology, 
Rockford, IL; #23225).   
Immunoblotting. Equal amounts of protein from each sample were mixed with 6× 
Laemmli buffer, boiled with SDS loading buffer for 5 min, separated by 10% SDS-
PAGE, and then transferred to nitrocellulose.  Membranes were rinsed with Tris-buffered 
saline plus Tween-20 (TBST; 0.14 mol/l NaCl, 0.02 mol/l Tris base, pH 7.6, and 0.1% 
Tween-20), blocked with 5% bovine serum albumin (BSA) in TBST for 1 h at room 
temperature and transferred to primary antibody 1:1000 in TBST plus 5% BSA overnight 
at 4°C.  Blots were washed 3 x 5 min with TBST and incubated in buffer containing the 
appropriate secondary antibody (1:20,000 dilution) for 1 h at room temperature.  
Membranes were then washed 3 x 5 min with TBST and subjected to enhanced 
chemiluminescence with West Dura Extended Duration Substrate (Pierce; #34075) for 
visualization of protein bands. Immunoreactive proteins were quantified by densitometry 
(AlphaEase FC, Alpha Innotech, San Leandro, CA).  
  
2-Deoxy-D-glucose Uptake. Aliquots (200 µl)  of the supernatants were combined in a 
vial with 10 ml of scintillation cocktail (Research Products International, Mount 
Prospect, IL) and a scintillation counter (Perkin Elmer, Waltman, MA) was used to 
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determine  3H and 14C disintegrations per min.  These values were used to determine 
[3H]-2-DG uptake as previously described (110, 111).   
 
Statistical Analysis. A student’s t-test was used to compare AL and CR groups.  Data are 
presented as mean ± SEM.  A P value < 0.05 was considered statistically significant.   
 
RESULTS 
Food Intake, Body Mass and Mass of Muscle Strips 
As intended, daily food intake for AL rats (18.4±1.46 g) was greater (P< 0.01) 
than for CR rats (12.0±1.02 g; 65% of AL), and as expected, body mass was greater (P< 
0.05) for AL (533±7 g) versus CR (302.5±1.8 g) rats.   Also as expected, the masses of 
the muscle strips used for ex vivo incubation were greater for the soleus (P< 0.01) of AL 
(51.7 ±2.5 mg) versus CR (42.0 ±2.4 mg) rats and for the epitrochlearis (P< 0.001) of AL 
(84.2 ±3.2 mg) versus CR (58.5 ±2.2 mg) rats.    
2-Deoxy-D-glucose Uptake 
2-DG uptake in the absence of insulin for both the epitrochlearis (P = 0.34) and 
soleus (P = 0.041) was not significantly different between AL and CR rats (Figure 1).  2-
DG uptake with insulin was significantly greater (P < 0.05) for CR versus AL rats in both 
the epitrochlearis (56% increase) and the soleus (40% increase). 
Protein Abundance 
Insulin receptor abundance for the CR versus AL group was increased 
significantly in the epitrochlearis (35% increase; P<0.005) and tended to increase in the 
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soleus (P=0.056) (Figure 2).  Akt abundance was decreased slightly for the CR compared 
to AL group in the epitrochlearis (9% decrease; P<0.05) (Figure 2).  Akt abundance was 
increased with CR versus AL in the soleus (15% increase; P<0.01). Filamin C abundance 
did not change with diet in the epitrochlearis.  Filamin C was increased (62% increase; 
P<0.05) with CR versus AL in the soleus muscle.  Neither total AS160 nor GLUT4 
abundance in either muscle differed for AL versus CR rats (Figure 2). 
Insulin Receptor Phosphorylation 
In the epitrochlearis, there were no diet effects on insulin receptor 
phosphorylation either with or without insulin (Figure 3). There were also no significant 
diet effects on insulin receptor phosphorylation in the soleus with or without insulin.  
Akt Phosphorylation  
In the absence of insulin, there was no diet effect observed on Akt 
phosphorylation on either T308 (Figure 4) or S473 (Figure 5) in the epitrochlearis or 
soleus.  In both the epitrochlearis and the soleus under insulin-stimulated conditions, Akt 
phosphorylation was increased on both T308 (300% in epitrochlearis, P<0.001; and 
177% in soleus, P<0.001) and S473 (350% increase in epitrochlearis, P<0.001; and 94% 
in soleus, P<0.001) for CR versus AL rats.   
AS160 Phosphorylation 
In both the epitrochlearis and soleus muscle, phosphorylation of AS160 at both 
the T642 (Figure 6) and S588 (Figure 7) sites did not differ between AL and CR animals 




In both the epitrochlearis and soleus muscle, phosphorylation of TBC1D1 at the 
T596 site did not differ between AL and CR animals in either the absence or the presence 
of insulin stimulation (Figure 8). 
Filamin C Phosphorylation 
In the absence of insulin, there was no diet effect observed on FLNc 
phosphorylation on S2213 in the epitrochlearis or soleus (Figure 9).  In both the 
epitrochlearis and the soleus under insulin-stimulated conditions, FLNc phosphorylation 
was increased on S2213 (52% in epitrochlearis, P<0.05; and 110% in soleus, P<0.05) for 
CR versus AL rats. 
DISCUSSION 
We  previously demonstrated in 23 month-old rats that CR leads to increased 
insulin-stimulated glucose uptake by the predominantly type II epitrochlearis muscle (4, 
21), but the influence of CR on glucose uptake in primarily type I skeletal muscle from 
old rats had not been previously reported.  It was important to fill this gap in knowledge 
because the insulin-stimulated glucose uptake  rates of muscles composed of primarily 
type I fibers are approximately 2-fold greater than muscles composed of predominantly  
type II fibers (24, 80, 84).  Furthermore, relatively greater age-related insulin resistance 
has been reported for predominantly type I versus predominantly type II muscles from 
older rats (84, 112). The most important new findings of the current study for isolated 
skeletal muscles with a physiological insulin concentration, old (24 month-old) CR 
versus AL rats were:  1) glucose uptake was enhanced for both type I soleus and type II 
epitrochlearis; 2) GLUT4 abundance was unchanged in both the soleus and 
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epitrochlearis; 3) insulin receptor phosphorylation was not altered by diet in either soleus 
or epitrochlearis; 4) Akt phosphorylation was enhanced in both the soleus and 
epitrochlearis; 5) AS160 phosphorylation at both T642 and S588 was unchanged by diet 
in both the soleus and epitrochlearis; 6) TBC1D1 phosphorylation at T596 was 
unchanged by diet in both soleus and epitrochlearis; and 7) Filamin C phosphorylation at 
S2213 was greater for CR versus AL rats in both soleus and epitrochlearis.     
Total GLUT4 abundance is highly correlated to the capacity for insulin-stimulated 
glucose uptake in rat skeletal muscle (80).  However, total GLUT4 content was unaltered 
by CR in both the epitrochlearis and the soleus.  These results were consistent with the 
previously published data for the CR effect on GLUT4 in skeletal muscle of old rats. 
Wang et al reported that CR did not alter total GLUT4 content in the diaphragm of 29 
month-old rats (6).  Because the diaphragm contracts continuously, and chronic 
contraction can increase GLUT4 expression (113), the results of the current study for the 
soleus and epitrochlearis provided valuable new information.  The absence of a CR effect 
on GLUT4 abundance in the soleus of 24 month-old rats is consistent with the results that 
we previously reported for the soleus of 9 month-old rats (24).  GLUT4  abundance in the 
epitrochlearis was also unaltered by CR in 24 month-old rats, consistent with our 
previous results for the epitrochlearis of 8 month-old rats (4).  However, in a recent study 
we found a modest (22%) CR-induced increase in GLUT4 abundance in the 
epitrochlearis of 9 month-old rats (24).  CR did not result in altered GLUT4 abundance in 
the vastus lateralis muscle from adult rhesus monkeys (5).  GLUT4 abundance in 
hindlimb muscles from mice were unaltered (89, 90) or increased (7) in response to CR.   
Taken together, a number of previous studies have established that even though skeletal 
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muscle GLUT4 abundance is often unaltered by CR, improved insulin sensitivity is 
consistently reported with CR in adults.  Furthermore, the current results clearly 
demonstrate that enhanced insulin-stimulated glucose uptake can occur in both type I and 
type II muscles of old rats in the absence of increased GLUT4 expression.  The CR-
induced enhancement on insulin-mediated glucose uptake in isolated epitrochlearis 
muscles from 5.5 month-old rats is attributable to a proportional increase in GLUT4 
translocation to the cell surface (3).  It seems reasonable to suspect that greater GLUT4 
translocation may also mediate the CR-related elevation in insulin-stimulated glucose 
uptake of muscles from old rats.  Because GLUT4 translocation is regulated by the 
insulin signaling pathway, it was important that we also evaluated CR effects on key 
insulin signaling steps in muscles from old rats.  
There was no CR effect on tyrosine1162/1163 phosphorylation of the insulin 
receptor for either muscle with a physiologic insulin dose. These tyrosine residues on the 
insulin receptor’s β subunit are major regulatory sites that account for most of the 
receptor’s insulin-mediated autophosphorylation and tyrosine kinase activity (58).  
Furthermore, replacement of both of these tyrosine residues with phenylalanine residues 
results in a marked reduction of insulin-stimulated 2DG uptake (58).   The lack of a CR-
related increase in insulin receptor tyrosine phosphorylation was found despite a 
moderate (35%) increase for insulin receptor abundance of the epitrochlearis of CR 
compared to AL rats.  These results for insulin receptor abundance are reminiscent of the 
previously reported modest increase (~19%) in insulin receptor binding capacity (Bmax) 
for CR versus AL rats in the diaphragm of 29 month-old rats (6).  Zhu et al. (26, 27) 
reported that after 25 month-old rats were injected with a high dose of insulin into the 
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portal vein, gastrocnemius muscle (predominantly type II fibers) from CR compared to 
AL animals had greater insulin receptor tyrosine phosphorylation.  In 9 month-old rats, 
we previously reported no significant CR compared to AL differences for tyrosine 
phosphorylation of the insulin receptor from soleus or epitrochlearis muscles incubated 
with a physiologic insulin dose, but there was a CR-related increase in both muscles with 
a supraphysiologic insulin concentration (24).  These results suggest that CR effects on 
tyrosine phosphorylation of the insulin receptor in skeletal muscle may be insulin dose-
dependent.  Furthermore, the CR-related amplification of post-receptor signaling and 
glucose uptake in muscle stimulated by a physiologic insulin dose in the current study do 
not appear to be attributable to greater tyrosine phosphorylation of the insulin receptor.  
We have consistently found a robust CR-induced increase in skeletal muscle Akt 
phosphorylation in skeletal muscle (both soleus and epitrochlearis) of young adult rats or 
mice (8-10, 24).   The current study was the first to assess the influence of CR on Akt 
phosphorylation in skeletal muscle from old rats.  Consistent with earlier results, CR 
versus AL rats had a striking increase in insulin-stimulated phosphorylation of the key 
regulatory sites of Akt (T308 and S473) in both muscles.  The small CR effects on Akt 
abundance (15% increase in soleus and 9% decrease in epitrochlearis) were insufficient 
to account for the marked (177% increase in soleus and 300% increase in epitrochlearis 
for T308; 94% increase in soleus and 350% increase in epitrochlearis for S473) increases 
for Akt phosphorylation with CR.  The dramatic increases in Akt phosphorylation with 
CR at a physiologic insulin dose occurred without an apparent change in upstream 
signaling at the insulin receptor, and these data are consistent with our previous results 
for the effect of CR on the soleus and epitrochlearis for 9 month-old rats (24).  
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AS160 is an Akt substrate and the most distal insulin signaling protein that is 
clearly implicated in insulin-mediated activation of glucose uptake in skeletal muscle (50, 
109).  The ability to phosphorylate AS160 on T642 and S588 is essential for the full 
effect of insulin on GLUT4 translocation and glucose uptake (18, 19, 50, 74).   However, 
we found no evidence for diet-related changes in insulin-stimulated T642 or S588 
phosphorylation in either the epitrochlearis or soleus muscle of old rats.  Consistent with 
the current results, we previously reported that T642 phosphorylation of the insulin-
stimulated soleus was unaltered by CR for 9 month-old rats (24). The lack of a CR effect 
on T642 or S588 phosphorylation of AS160 in the epitrochlearis with physiologic insulin 
in 24 month-old rat differs from the CR-related increase in T642 and S588 for the 
epitrochlearis  of 9 month-old rats (24).  The explanation for the different results for T642 
and S588 in the epitrochlearis of adult compared to old rats remains to be determined.     
TBC1D1 is an Akt substrate and has been implicated in the regulation of glucose 
uptake(50, 109).  In the absence of AS160 phosphoryation, one plausible scenario would 
be that TBC1D1 may play a role in the CR-mediated increase in insulin-stimulated 
glucose uptake in old rats.  However, we found no evidence of enhanced phosphorylation 
of T596 in either epitrochlearis or soleus muscles. An alternative possibility is that CR 
may lead to greater phosphorylation of another Akt substrate that modulates glucose 
transport.   In this context, it was interesting that CR resulted in greater phosphorylation 
of filamin C in the insulin-stimulated epitrochlearis and soleus muscles.  Filamin C was 
previously identified as a substrate of Akt that in C2C12 myocytes incubated with insulin 
becomes phosphorylated on Ser2213 (76). Insulin-regulated remodeling of actin 
filaments has been implicated in the control of both the spatial localization of insulin 
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signaling proteins and translocation of GLUT4 glucose transporter vesicles (78).  Sharma 
et al. (unpublished results), studying isolated epitrochlearis from 9 month-old rats, also 
found a CR-induced increase in insulin-stimulated filamin C phosphorylation.   They 
further found that a low dose of a highly selective Akt inhibitor that eliminated the CR-
induced increase in Akt phosphorylation also eliminated the CR-induced increases in 
both glucose uptake and filamin C phosphorylation of the insulin-stimulated 
epitrochlearis.   We demonstrated in this study that insulin-stimulated filamin C 
phosphorylation at S2213 is enhanced with CR in both the epitrochlearis and soleus 
muscles from old rats.  It should be noted that in the soleus, but not the epitrochlearis, the 
greater filamin C phosphorylation (110%) in CR rats is likely at least in part attributable 
to an increase (62%) in total filamin C abundance.  If the filamin C phosphorylation of 
the soleus is expressed as a ratio of total filamin C abundance, there is no longer a 
statistically significant difference between the AL and CR rats. Regardless, it is unclear if 
filamin C plays any role in the regulation of glucose transport, and the functional 
significance of the observed CR-related increase in insulin-mediated phosphorylation of 
filamin C is unknown. 
In conclusion, the most significant new result was that the CR-effect on insulin-
stimulated glucose uptake was well-preserved for both type I soleus and type II 
epitrochlearis of old rats.  Furthermore, in both muscles, it seems likely that this increase 
is secondary, at least in part, to greater insulin-stimulated Akt phosphorylation.  
However, in neither muscle was insulin-stimulated AS160 (T642 and S588) 
phosphorylation or TBC1D1 T596 phosphorylation enhanced by CR. Earlier research in 
adult (9 month-old) rats implicated CR-induced elevation in phosphorylation of Akt and 
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AS160 as likely important for the greater insuln-stimulated glucose transport in the 
epitrochlearis muscle (24).  The results of the current study suggest that the mechanisms 
for improved insulin-stimulated glucose uptake in the epitrochlearis with CR may not be 
completely identical for adult compared to old rats.  In both the current study and the 
previous study of 9 month-old rats, greater insulin-stimulated glucose transport in the 
soleus was accompanied by greater Akt phosphorylation in the absence of enhanced 
phosphorylation of either AS160 or TBC1D1. An interesting finding of uncertain 
functional significance was that CR resulted in greater S2113 phosphorylation of filamin 
C in insulin-stimulated epitrochlearis and soleus muscles.  Future research should focus 
on determining if the CR effect on filamin C phosphorylation plays a role in greater 
insulin-stimulated glucose transport in either the epitrochlearis or soleus of old rats.   
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Figure 3.1 2-Deoxy-D-glucose (2-DG) uptake in isolated epitrochlearis and soleus 
from old rats. 2-DG in epitrochlearis (A) and soleus (B) muscles with 0 or 1.2nM 
insulin.  *p<0.05, CR versus AL in the same insulin treatment group.  Data are means ± 
SEM.  n=9-11 muscles per diet group and insulin concentration.   Open bars represent AL 




Figure 3.2 Total protein abundance in isolated epitrochlearis and soleus from old 
rats. Total protein abundance in epitrochlearis (A) and soleus (B) muscles for IR (insulin 
receptor), Akt, AS160,  FLN C (Filamin C) and GLUT4.  *p<0.05, CR versus AL. Open 




Figure 3.3 Insulin receptor tyrosine phosphorylation (IRTyr1162/1163) in isolated 
epitrochlearis and soleus from old rats. IRTyr1162/1163 in the epitrochlearis (A) and 
soleus (B) muscles with 0 or 1.2 nM insulin.  *p<0.05, CR versus AL in the same insulin 
treatment group.    Data are means ± SEM.  n=9-11 muscles per diet group and insulin 












Figure 3.4 AktThr308 phosphorylation in isolated epitrochlearis and soleus from old 
rats. AktThr308 phosphorylation in epitrochlearis (A) and soleus (B) muscles with 0 or 
1.2nM insulin .  *p<0.05, CR versus AL in the same insulin treatment group.  Data are 
means ± SEM.  n=9-11 muscles per diet group and insulin concentration.  Open bars 












Figure 3.5 AktSer473 phosphorylation in isolated epitrochlearis and soleus from old 
rats. AktSer473 phosphorylation in epitrochlearis (A) and soleus (B) muscles with 0 or 
1.2nM insulin. Data are means ± SEM.  n=9-11 muscles per diet group and insulin 












Figure 3.6 AS160Thr642 phosphorylation in isolated epitrochlearis and soleus from 
old rats. AS160Thr642  phosphorylation in epitrochlearis (A) and soleus (B) muscles with 
0 or 1.2 nM insulin. Data are means ± SEM.  n=9-11 muscles per dietary group and 












Figure 3.7 AS160Ser588 phosphorylation in isolated epitrochlearis and soleus from old 
rats. AS160Ser588  phosphorylation in epitrochlearis (A) and soleus (B) muscles with 0 or 
1.2 nM insulin. Data are means ± SEM.  n=9-11 muscles per dietary group and insulin 












Figure 3.8  TBC1D1Thr596 phosphorylation in isolated epitrochlearis and soleus from 
old rats. TBC1D1Thr596  phosphorylation in epitrochlearis (A) and soleus (B) muscles 
with 0 or 1.2 nM insulin. Data are means ± SEM.  n=9-11 muscles per dietary group and 











Figure 3.9 Filamin CSer2213  phosphorylation in isolated epitrochlearis and soleus 
from old rats. Filamin CSer2213  phosphorylation in epitrochlearis (A) and soleus (B) 
muscles with 0 or 1.2 nM insulin. Data are means ± SEM.  n=9-11 muscles per dietary 













Comparison of Ad Libitum Fed and Calorie Restricted Rats for the Time Course of 
Insulin’s Activation of Signaling Steps Required for Greater Glucose Transport by 





 Calorie restriction (CR) induces enhanced insulin-stimulated glucose uptake but 
the mechanisms responsible are not fully understood.  Earlier studies with isolated rat 
skeletal muscle from rats found CR versus AL animals had greater insulin-stimulated Akt 
phosphorylation and glucose uptake without diet-effects on key insulin signaling steps 
proximal to Akt.  However, it seemed possible that transient CR effects may have been 
missed because the signaling effects were made after 45-50 minutes of insulin exposure.   
Accordingly, the purpose of this study was to evaluate the time course of insulin action 
on insulin receptor (IR) tyrosine phosphorylation, insulin receptor substrate1 (IRS-1) 
tyrosine phosphorylation, IRS-1 associated PI3K activity, and Akt phosphorylation in 
isolated soleus muscles from AL and CR rats with a physiologic dose of insulin for 5, 15, 
and 50 minutes in soleus muscles from 9 month-old ad libitum (AL) fed and CR 
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(consuming 65% of ad libitum, AL, intake) Fisher 344/Brown Norway rats. Insulin-
stimulated 2-deoxyglucose uptake was significantly increased for CR versus AL rats. 
There were no significant differences between muscles from CR and AL rats for 
phosphorylation of the IR on Tyr1162/1163, tyrosine phosphorylation of IRS-1 or IRS-1 
associated PI3K at any time point with or without insulin.  There was no significant effect 
of diet for Akt Thr308 and Ser473 phosphorylation at any time point under basal 
conditions.  However, Akt phosphorylation on both Thr308 and Ser473 was significantly 
increased for the CR versus AL group in muscles that were incubated with insulin for 50 
minutes, but not for muscles incubated with insulin for 5 or 15 minutes. The results 
suggest that the greater Akt phosphorylation and glucose uptake in the muscles from CR 
rats were attributable to mechanisms independent of diet-related elevations in the levels 
of IR, IRS-1, and IRS-1 associated PI3K.   Our working hypothesis is that the improved 
Akt activation with CR is related to altered Akt binding to protein partners (TRB3, 




 One of the hallmarks of calorie restriction (CR; i.e., consuming ~60-75% of ad 
libitum, AL, intake) is an increase in whole body insulin sensitivity (39-41, 106).  Given 
that skeletal muscle accounts for the greatest amount of whole body glucose disposal (2), 
it is not surprising that CR leads to increased insulin-mediated glucose uptake by skeletal 
muscle (38, 53, 54).  Dean et al. (3) demonstrated that the increased glucose uptake with 
CR is attributable to a proportional CR-mediated increase in the cell surface GLUT4 at 
the plasma membrane in insulin-stimulated rat skeletal muscle.  The effect of CR on 
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insulin-stimulated glucose uptake can occur in the absence of increased total GLUT4 
protein abundance (88).  These results suggest that the mechanism for the CR effect on 
skeletal muscle glucose transport is related to the specific enhancement of the insulin 
signaling pathway leading to increase GLUT4 recruitment to the plasma membrane.  
Most (24, 28-30, 114), but not all (6) of the published studies that have evaluated 
CR effects on skeletal muscle insulin receptor (IR) activation with physiologic insulin 
levels have not found diet-induced differences.  In our previous studies, there were no 
significant diet effects on IR tyrosine phosphorylation (24, 114) or IRS1-PI3K activity 
(24) with a physiologic insulin concentration.  Phosphorylation of Akt (also known as 
protein kinase B, PKB) on both Ser473 and Thr308 is essential for the full effect of 
insulin on glucose transport (8).  In this context, it is notable that the most consistent 
result of a series of studies on isolated muscles from CR versus AL rodents has been 
elevated insulin-induced phosphorylation of Akt for isolated muscles from CR rats (9, 10, 
24) and mice (8). These results together suggest elevation in Akt phosphorylation with 
CR was not attributable to enhancement in insulin receptor or IRS1-PI3K activity. 
However, enhanced Akt phosphorylation without enhanced IR and IRS-1-PI3Kactivation 
for CR versus AL was measured at 50 minutes of insulin stimulation so it is possible 
these observations are attributable to reversal of transient CR effect on proximal steps of 
insulin signaling that may have reversed by the 50 minute time point.  The primary aim 
of this study was to determine the time course of insulin signaling with CR versus AL in 
response to a physiological insulin dose.   In isolated soleus muscle from AL and CR rats, 
we evaluated key upstream insulin signaling proteins [tyrosine phosphorylation of the 
insulin receptor (IR) and insulin receptor substrate 1(IRS-1) and IRS-1 associated 
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phosphatidylinositol 3-kinase (PI3K) activity] with insulin stimulation at 5, 15 and 50 
minutes.  We hypothesized that phosphorylation of IRTyr1162/1163 and IRS-1Tyr, and PI3K-
IRS-1 activity would be greater for CR versus AL with insulin stimulation at 5 and 15 
minutes, but not at 50 minutes of insulin exposure.  We also measured insulin-stimulated 




Materials. Unless otherwise noted, all chemicals were purchased from Sigma Chemical 
(St. Louis, MO) or Fisher Scientific (Hanover Park, IL).  Human recombinant insulin was 
obtained from Eli Lilly (Indianapolis, IN). Tissue Protein Extraction Reagent (#78510) 
was from Thermo Scientific (Rockford, IL). MILLIPLEXMAP cell signaling buffer and 
detection Kit (#48-602), MILLIPLEX phospho-MAPmates for IRTyr1162/1163(#46-688), 
IRS1Tyr (#46-627), AktSer473 (#46-601), AktThr308 (#46-645), total MAPmates for Akt 
(#46-605), IR (#46-687), and IRS1 (#46-628) were all purchased from Millipore 
(Billerica, MA). Reagents and apparatus for SDS-PAGE and immunoblotting were from 
Bio-Rad Laboratories (Hercules, CA). Anti-Akt (#9272), anti-phospho AktSer473 
(pAktSer473; #9271), and anti-rabbit IgG horseradish peroxidase (#7074) were from Cell 
Signaling Technology (Danvers, MA). Pierce BCA (bicinchoninic acid) protein assay 
(#23225) and West Dura Extended Duration Substrate (#34075) were from Pierce 
Biotechnology (Rockford, IL). Scintillation counter, 2-Deoxy-D-[3H] glucose ([3H] 2-
DG), [14C]mannitol, and γ-[32P]ATP were from Perkin Elmer (Boston, MA). Scintillation 
cocktail # 111195 was from Research Products International (Mount Prospect, IL). A-
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Sepharose beads (#17-0469-01) were from GE Healthcare (Piscataway, NJ).  
Phosphatidylinositol (PI) was from Avanti Polar Lipids (Alabaster, AL). TLC plates 
#4865-821 were from Whatman (Piscataway, NJ).  
 
Animal Care.  Procedures for animal care were approved by the University of Michigan 
Committee on Use and Care of Animals. CR and AL male Fischer 344 × Brown Norway, 
F1 generation rats were obtained at 8 months of age from the National Institute of 
Aging(NIA) Calorie Restriction Colony and were individually housed for a month prior 
to experimentation.  CR was initiated with NIA colony at 14 weeks of age with 90% of 
AL, increased to 75% of AL at 15 weeks, and to 60% of AL at 16 weeks, a level 
maintained until 8 months of age.   Upon arrival at the Michigan animal facility at 8 
months-old, rats were housed individually in shoebox cages and maintained on a 12:12-h 
light-dark cycle (lights out at 1700) in specific pathogen-free conditions.  The AL group 
had ad libitum access to the NIH31 chow for the duration of the study. The CR group 
received NIH31/NIA fortified chow (Test Diet), which contains extra vitamin 
supplementation to provide CR animals with a level of vitamins similar to that of animals 
allowed ad libitum access to the NIH31 diet. The CR group received 60-65% of the 
intake of the AL group daily during the final month of the study.  All rats were fed 
between 15:30 h and 16:30 h each day, and food intake of both groups was measured 
daily.  Muscle experiments were performed on AL (N=14 and CR (N=14) rats at 9 




Muscle Dissection and Incubation.  Food was removed from the cages of all rats on the 
morning of the experimental day between 07:00 and 08:00 h.  Rats were anesthetized 
with an intraperitoneal injection of sodium pentobarbital (50 mg/kg) between 10:30 and 
13:30 h.  Upon loss of pedal reflexes, soleus and epitrochlearis muscles were removed 
and rapidly rinsed in warm (35oC) Krebs-Henseleit buffer (KHB).  Muscles were 
longitudinally split into strips of similar size for each muscle (4 strips for each soleus).  
Muscles strips were subsequently placed in vials containing the appropriate media 
shaking and continuous gassing (95% O2/5% CO2) in a heated (35
oC) water bath. In the 
first incubation step, all muscles were incubated in vials containing 2 ml KHB 
supplemented with 0.1% bovine serum albumin (BSA), 2mM sodium pyruvate, 6mM 
mannitol as a rinse step for 30 minutes.   In the second incubation step, muscles were 
incubated in vials containing 2 ml KHB supplemented with 0.1% BSA, 2 mM sodium 
pyruvate, 6 mM mannitol, and either 0 nM (basal) or 1.2 nM insulin for 5 min, 15 min, or 
30 min.  The muscles incubated in the second step for 5 minutes and 15 minutes were 
then rapidly blotted on filter paper moistened with ice-cold KHB, trimmed, freeze-
clamped using aluminum tongs cooled in liquid nitrogen, and stored at -80oC for later 
processing and analysis.   The remaining muscles were either transferred to a third vial 
containing 2 ml of KHB/BSA solution, the same insulin concentration as the previous 
step with 0.1% BSA, 2 mM sodium pyruvate, 6 mM mannitol for 20 minutes or to assay 
for 2-Deoxy-D-glucose uptake transferred to a third vial containing 2 ml of KHB/BSA 
solution, the same insulin concentration as the previous step, 1 mM 2-DG; including a 
final specific activity of 2.25 mCi/mmol [3H]-2-DG), and 9 mM mannitol (including a 
final specific activity of 0.022 mCi/mmol [14C]-mannitol) for 20 min.  Following the 
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third incubation step, the muscles were rapidly blotted on filter paper moistened with ice-
cold KHB, trimmed, freeze-clamped using aluminum tongs cooled in liquid nitrogen, and 
stored at -80oC for later processing and analysis. 
 
Muscle Lysate Preparation.  Frozen muscles were weighed, transferred to microfuge 
tubes and homogenized in ice-cold lysis buffer (1 ml/muscle) using Qiagen a TissueLyser 
II (Valencia, CA).  The lysis buffer contained Tissue Protein Extraction Reagent 
supplemented with 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM 
sodium vanadate (Na3VO4),
 1 mM ß-glycerophosphate, 1 µg/ml leupeptin, and 1 mM 
phenylmethylsulfonyl fluoride (PMSF).   Homogenates  were transferred to microfuge 
tubes, rotated for 1 h at 4°C, and then centrifuged (15,000 g) for 15 min (4oC) to remove 
insoluble material.  Protein concentration was measured using the bicinchoninic acid 
method. 
 
Immunoblotting.  Equal amounts of protein from each sample were mixed with 6× 
Laemmli buffer, boiled with SDS loading buffer for 5 min, separated by 10% SDS-
PAGE, and then transferred to nitrocellulose.  Membranes were rinsed with Tris-buffered 
saline plus Tween-20 (TBST; 0.14 mol/l NaCl, 0.02 mol/l Tris base, pH 7.6, and 0.1% 
Tween-20), blocked with 5% bovine serum albumin (BSA) in TBST for 1 h at room 
temperature and transferred to primary antibody 1:1000 in TBST plus 5% BSA overnight 
at 4°C.  Blots were washed 3 x 5 min with TBST and incubated in buffer containing the 
appropriate secondary antibody (1:20,000 dilution) for 1 h at room temperature.  
Membranes were then washed 3 x 5 min with TBST and subjected to enhanced 
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chemiluminescence with West Dura Extended Duration Substrate for visualization of 
protein bands.  Immunoreactive proteins were quantified by densitometry (AlphaEase 
FC, Alpha Innotech, San Leandro, CA).   
 
2-Deoxy-D-glucose Uptake.  Aliquots (200 µl) of the supernatants were combined in a 
vial with 10 ml of scintillation cocktail (Research Products International, Mount 
Prospect, IL) and a scintillation counter was used to determine 3H and 14C disintegrations 
per min.  These values were used to determine [3H]-2-DG uptake as previously described 
(110, 111). 
 
 IRS-1-associated PI3K activity.  IRS1-PI3K activity in the soleus muscle was 
determined as previously described (23, 24).  After addition of 3 μg of anti-IRS-1 
antibody to 500 μg of supernatant protein from each muscle sample, the 
immunocomplexes were allowed to form overnight at 4°C with slow rotation.  Then 100 
μl of protein A-Sepharose beads were then added to each aliquot, and samples were 
rotated for 2 h at 4°C.  Samples were centrifuged at 2,000 g to pellet the protein A-
Sepharose immunocomplex.  Each immunopellet was washed three times with Buffer 
1 (PBS, pH 7.5, containing 1% NP-40 and 100 μM Na3VO4), three times with Buffer 
2 (100 mM Tris, pH 7.5, 500 mM LiCl2, and 100 μM Na3VO4), and twice with Buffer 
3 (10 mM Tris, pH 7.5, 100 mM NaCl, 1 mM EDTA, and 100 μM Na3VO4).  After the 
immunopellet was washed, the entire buffer was removed, and the immunopellet was 
resuspended in 40 μl of the Tris·NaCl, pH 7.5, buffer containing 20 μg of 
phosphatidylinositol and 100 mM MgCl2. The reaction was initiated at room temperature 
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by addition of 5 μl of a phosphorylation mixture containing 880 μM ATP and 30 μCi of 
γ-[32P]ATP.  After 40 min with continuous rotation at 30°C, the reaction was stopped by 
sequential addition of 20 μl of 8 N HCl and 160 μl of chloroform-methanol (1:1).  The 
reaction mixture was vortexed for 5 min and then centrifuged at 15,000 g for 2 min; 50 μl 
of the organic phase containing the reaction products was spotted onto a TLC plate. The 
products were resolved in a chloroform-methanol-water-ammonium hydroxide 
(60:47:11.3:2) solution and visualized by autoradiography.  The spots corresponding to 
the PI phosphorylated product were scraped from the TLC plate and counted in a 
scintillation counter.  
 
Luminex.  Luminex analysis was performed by the Luminex L200 instrument (Luminex, 
Austin, TX), as described previously (115).  An aliquot of lysate from each tissue was 
used to determine the phosphorylation status of insulin signaling proteins (IRTyr1162/1163, 
IRS-1Tyr, AktSer473, AktThr308) using a commercially available kit (#48-602, Millipore). 
Another aliquot from each tissue sample was used in a second multiplex assay to 
determine the relative abundance of proteins (IR, IRS1, Akt). 
   
Statistical Analysis.  3-way ANOVA was used to determine the main effects of Insulin (0 
or 1.2nM), Time (5, 15 or 15 min) and Diet (AL or CR) on insulin signaling in the soleus 
muscles (pIR Tyr1162/1163, pIRS-1Tyr, PI3K-IRS-1 activity, pAktSer473, and pAktThr308).  A 
student’s t-test was used to compare AL and CR groups for 2-DG uptake and insulin 
signaling matched for both time-point and insulin dose. Data are presented as mean ± 








2-DG uptake in the absence of insulin was not significantly different between AL 
and CR rats.  2-DG uptake with insulin was significantly greater (P<0.05) for CR versus 
AL rats (Figure 1).  
 
IRTyr1162/1163 Phosphorylation Time Course   
 
ANOVA revealed that there was a non-significant trend for a main effect of 
insulin (P=0.058), but no evidence for main effects of either time or diet on IR 
Tyr1162/1163 phosphorylation (Figure 2).   Based on t-tests comparing AL versus CR 
values at each insulin dose and time, there were no significant effects of diet on IR 
phosphorylation on Tyr1162/1163, either in the absence or presence of insulin (Table1). 
 
IRS-1Tyr Phosphorylation Time Course 
 
ANOVA revealed that there was significant main effect insulin (P<0.005), but no 
evidence for main effects of either time or diet on IRS-1 Tyr phosphorylation (Figure 2). 
Based on t-tests comparing AL versus CR values at each insulin dose and time, there 
were no significant diet effects on IRS-1 phosphorylation, either in the absence or 
presence of insulin (Table 1).  
 
IRS-1 associated PI3K Activity Time Course 
 
ANOVA revealed that there was a significant main effect of insulin (P<0.001), 
but no evidence for main effects of either time or diet on IRS-1 associated PI3K activity 
(Figure 2).  Based on t-tests comparing AL versus CR values at each insulin dose and 
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time, there was no significant diet effect seen on IRS-1 associated PI3K activity, either in 
the absence or presence of insulin (Table 1).  
 
AktThr308 Phosphorylation Time Course 
ANOVA revealed that there were significant main effects of insulin (P<0.001), 
time (P<0.05), and diet (P<0.05) on Akt Thr308 phosphorylation (Figure 3).  Based on t-
tests comparing AL versus CR values in the absence of insulin at each time, there were 
no significant diet effects on Akt Thr308 phosphorylation (Table 1).  The results of the t-
tests comparing AL versus CR values at each time in the presence of insulin also revealed 
no significant diet effects on Akt phosphorylation on Thr308 at 5 or 15 minutes, but at 50 
minutes, Akt phosphorylation on Thr308 was significantly greater (P<0.05) for CR 
versus AL rats (Table 1).  
 
AktSer473 Phosphorylation Time Course 
 
ANOVA revealed that there were significant main effects of insulin (P<0.001) 
and diet (P<0.05), but not time on Akt Ser473 phosphorylation (Figure 3).  Based on t-
tests comparing AL versus CR values in the absence of insulin at each time, there were 
no diet effects for Akt Ser473 phosphorylation (Table 1).  The results of the t-tests 
comparing AL versus CR values at each time in the presence of insulin also revealed no 
significant diet effects on Akt phosphorylation on Ser473 at 5 or 15 minutes, but at 50 
minutes, Akt phosphorylation on Thr308 was significantly greater (P<0.05) for CR 





Prior research has shown that CR can enhance insulin-stimulated glucose uptake 
in isolated muscle, and this effect consistently occurs concomitant with an increase in 
phosphorylation of Akt.  Several earlier studies of CR effects that used isolated rat 
skeletal muscle reported that CR did not induce significantly greater activation of key 
upstream insulin signaling steps (tyrosine phosphorylation of IR or IRS1, and IRS-1-
associated PI3K activity) that regulate Akt phosphorylation (3, 24, 25).   These results 
suggest that the mechanism for the CR-induced increase in Akt activation is not 
dependent on greater activation of these important proximal insulin signaling steps.  
However, because earlier studies had only evaluated the soleus at a single time-point of 
insulin exposure (50 minutes), it seemed possible that a transient CR-related activation 
might have been missed.  Therefore, we evaluated the time course of insulin action on 
insulin receptor (IR) tyrosine phosphorylation, insulin receptor substrate1 (IRS-1) 
tyrosine phosphorylation, IRS-1 associated PI3K, and Akt in isolated soleus muscles 
from AL and CR rats with a physiologic dose of insulin for 5, 15, and 50 minutes.  As 
expected, skeletal muscle 2-DG uptake was significantly increased with insulin for CR 
versus AL. There was no significant increase between muscles from CR and AL rats for 
phosphorylation of the IR on Tyr1162/1163 at any time point with or without insulin.  
Tyrosine phosphorylation of IRS-1 was also not significantly different between CR and 
AL rats regardless of insulin dose or time point.  There was also not significantly greater 
IRS-1 associated PI3K for CR versus AL at any time point with or without insulin.  There 
was no significant effect of diet for Akt Thr308 and Ser473 phosphorylation at any time 
point under basal conditions.  However, phosphorylation of Akt on both Thr308 and 
Ser473 was significantly increased for the CR versus AL group in muscles that were 
60 
 
incubated with insulin for 50 minutes, but not for muscles incubated with insulin for 5 or 
15 minutes.   
Muscle 2-DG uptake was increased with 50 minutes of insulin exposure for CR 
versus AL rats, indicating that, as expected, there was enhanced insulin sensitivity in the 
soleus muscles of the CR group.  The CR effect on insulin-stimulated glucose uptake has 
been seen numerous times before in the soleus and epitrochlearis muscles of rats (9, 10, 
24) and in the soleus, epitrochlearis and extensor digitoroum longus muscles of mice (8, 
37). The increased insulin-mediated glucose uptake is attributable to an increase in cell-
surface GLUT4 (3) and can occur without an increase in overall GLUT4 abundance (4, 
84, 114).  
IR phosphorylation has previously been shown to be similar between AL and CR 
rats with 50 minutes of insulin stimulation in 9 month and 24 month-old rats of the same 
strain used in this study (24, 114).  It was not clear, however, if transiently greater insulin 
receptor activation with CR may have occurred at an earlier timepoint and reversed by 50 
minutes.  In this study we show that IR phosphorylation at Tyr1162/1163 is similar 
between AL and CR rats at 5, 15, and 50 minutes of insulin stimulation.  These tyrosine 
residues on the insulin receptor’s β subunit are major regulatory sites that account for 
most of the receptor’s insulin-mediated autophosphorylation and tyrosine kinase activity 
(58).   Based on the current results, it appears that CR’s effects on more distal signaling 
in isolated soelus muscles from rats are attributable to some mechanism other than 
greater IR phosphorylation at Tyr1162/1163.   
The effect of CR on IRS-1 tyrosine phosphorylation has apparently not been 
studied in isolated rodent skeletal muscle with a submaximal insulin dose, but Dean and 
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Cartee (23) studied AL and CR rats that received a portal injection of a supraphysiologic 
insulin dose.  Gastrocnemius muscle pan-tyrosine phosphorylation of IRS-1 was greater 
for insulin-injected CR versus AL rats.   Wang et al. (116) evaluated pIRS-1Tyr612 in 
calorie restricted and ad libitum cytomolgus monkeys at 5, 20, and 40 minutes of insulin 
infusion (plasma insulin of ~1.5 nM) during a euglycemic-hyperinsulinemic clamp.  At 
40 minutes of insulin infusion, there was no significant CR versus AL effect on vastus 
lateralis muscle pIRS-1Tyr612.  However at both 5 and 20 minutes there were significant 
increases in IRS-1 phosphorylation at Tyr612. In our study we found no evidence for a 
CR versus AL increase in IRS-1 tyrosine phosphorylation at either 5, 15, or 50 minutes in 
the rat soleus muscle.  It is important to note that the current study evaluated pan-tyrosine 
phosphorylation whereas Wang et al. looked at the specific Tyr 612 site.   Pan-tyrosine 
IRS-1 phosphorylation was used to capture the multiple tyrosine phosphorylation sites on 
IRS-1 that are activated by insulin.  It remains to be determined if pIRS-1Tyr612 increases 
with CR versus AL in isolated rat soleus muscles.  It is also possible that other 
differences between the current study the study of Wang et al. account  for the differing 
results on the activation of tyrosine phosphorylation in skeletal muscle (e.g., differences 
in the species studied, specific muscles studied, in vivo versus ex vivo, etc.) 
Previous studies evaluating the effect of CR on IRS-1-, IRS-2- or 
phosphotyrosine-associated PI3K activity have reported no significant differences 
between CR versus AL rats in muscle exposed to 45 to 50 minutes with submaximally 
effective insulin doses in isolated epitrochlearis muscles from rats (24, 25) suggesting 
that the enhanced insulin sensitivity with CR is dependent on effects occurring 
downstream of IRS-1-PI3K signaling.  Dean et al. (3) evaluated IRS-1-PI3K activity in 
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with 4, 8, and 20 minutes of a supraphysiological insulin dose (120nM) and did not find a 
significant difference with CR versus AL at any time point.  However, a recent study by 
Schenk et al. (117) in isolated soleus muscle from mice found that phosphotyrosine-
associated PI3K activity increased with CR versus AL using 60 μU/ml insulin with10 
minutes of insulin stimulation. In CR versus AL, there was no change on insulin 
stimulation  of IRS1-, IRS2-, or phosphotyrosine-PI3K in rat epitrochlearis (25). Wang et 
al. (116) reported that in vastus lateralis muscle from calorie restricted monkeys, IRS-1 
associated PI3K activity was greater for CR versus AL with 5, 20, and 40 minutes of 
insulin stimulation. The current study and earlier studies with rats have not found 
significant CR effects on PI3K activity, whereas two studies that found CR effects on 
PI3K activity studied other species (mice and monkeys).   It remains possible that there 
may be species differences in PI3K activation with insulin for CR versus AL animals.   
In the current study, no significant differences between AL and CR rats were 
detected for IRS-1-PI3K activity in isolated rat soleus muscle at 5, 15, and 50 minutes 
with 1.2 nM insulin.  At least in isolated rat skeletal muscles, the results of multiple 
studies have not identified significant CR-induced elevations in IRS-1 PI3K activity, and 
the current study has extended earlier research by providing evidence at earlier time-
points than previously evaluated with a physiologic insulin dose.  The lack of a 
statistically detectable CR effect on proximal signaling concomitant with a consistently 
significant CR effect on Akt could potentially be related to differences in the technical 
precision of the methods used to quantify the different insulin signaling steps. The 
dynamic range was smaller and the variability was greater for proximal signaling markers 
versus Akt signaling.  It is possible that the lack of a statistically detectable CR effect of 
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proximal signaling steps in this study was due to insufficient sample size and statistical 
power.  Only 3 time points were assessed and a difference may have been missed at an 
intermediate time point that was not studied.  However, it is notable that the results of the 
current study are consistent with earlier studies for rat skeletal muscle.  Previously, no 
CR effect on IRS1-, IRS2, or phosphotyrosine PI3K was reported with 3 nM insulin in 
the epitrochlearis (25).  Sharma et al.  (24) observed no CR effect on PI3K activity 
together with no evidence for a CR effect on atypical PKC activity.  The lack of any 
change in atypical PKC activity with CR, a step that is dependent on the proximal 
signaling events that also regulate Akt (including insulin receptor and IRS-1 tyrosine 
phosphorylation and IRS-1-PI3K activity) is consistent with a lack of a general increase 
in proximal signaling with CR, and it supports the idea of CR does not uniformly enhance 
all signaling events that are modulated by insulin via activation of PI3K activity. 
The most consistent CR effect on insulin signaling in skeletal muscle that has 
been observed in numerous studies is greater Akt phosphorylation on the two key sites 
that regulate Akt activity (Thr308 and Ser473) (8-10, 24).  This effect has been 
repeatedly seen with both supraphysiologic and physiological levels of insulin.  Cho et al. 
(68) showed that Akt2 is the critical isoform for regulating most of the insulin-stimulated 
glucose transport in skeletal muscle.  In the current study, consistent with earlier research, 
Akt phosphorylation on Thr308 and Ser473 was significantly increased for CR versus AL 
at 50 minutes of insulin-treatment.  Akt phosphorylation was not significantly different 
between the diet groups at either 5 or 15 minutes, although there was a trend for higher 
values on Ser473 at both times and Thr308 at 15 minutes.  In insulin-infused cynomolgus 
monkeys, there were significant CR-related increases in Akt Ser473 phosphorylation at 5, 
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20 and 40 minutes (116). An earlier time of onset for the CR effect on pAkt with in vivo 
insulin infusion would be favored by the delivery of insulin via the vascular system as 
opposed to the diffusion of insulin from media to the tissue in isolated muscles, but there 
may also be other in vivo factors that would favor the more rapid time course for the CR-
effect.   
The lack of evidence for significant CR effects on proximal insulin signaling steps 
in isolated rat skeletal muscle at various early time-points begs the question, what might 
account for the greater Akt that is consistently found in rat skeletal muscle?  One 
possibility is that CR may influence the subcellular localization of Akt.  Full activation 
requires Akt insertion into the plasma membrane.  CR may increase the number of Akt 
molecules at the plasma membrane leading to greater activation.  However, it is unclear 
what might account for such a change in Akt localization with CR.  There is evidence 
that CR may alter the binding of Akt to proteins that lead to greater phosphorylation thus 
enhancing Akt signaling.  In the epitrochlearis muscles from 9 mo-old rats, CR versus AL 
animals had greater HSP90-bound to Akt (based on co-immunoprecipitation) 
concomitant with increased Akt phosphorylation.  However, there was no evidence of 
increased HSP90-Akt association in the soleus of CR rats in this earlier study.  It remains 
possible that CR may be improving Akt signaling in the soleus through alterations in the 
binding to other protein partners.   Because phosphorylation of proteins depends on the 
balance between the actions of kinases and phosphatases, another possibility is that CR 
reduces the rate of Akt dephosphorylation.  However, Sharma et al. (24) found in soleus 
and epitrochlearis muscles from 9 mo-old rats that there was no CR-related difference in 
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Akt association with Protein Phosphatase 2A (PP2A), the key Ser/Thr protein 
phosphatase that dephosphorylates Akt. 
In summary, the current study confirms earlier research that demonstrated 50 
minutes of exposure to a physiologic insulin dose is sufficient for enhanced glucose 
uptake concomitant with increased Akt phosphorylation in isolated muscles from CR 
versus AL rats.  We predicted that upstream signaling would be transiently (at 5 and/or 
15 minutes) greater for CR versus AL rats.  However, muscles from CR versus AL rats 
did not differ significantly for IRTyr1162/1163 phosphorylation, IRS-1Tyr phosphorylation, or 
IRS-1-associated PI3K activity, at any of the times tested (5, 15 and 50 minutes) 
suggesting that the greater Akt phosphorylation and glucose uptake in the muscles from 
CR rats were attributable to another mechanism.   Our working hypothesis is that the 
improved Akt activation with CR is related to altered Akt binding to protein partners that 
regulate Akt phosphorylation.   It will be important for future research to test this idea by 
evaluating Akt binding to proteins that have been reported to favor greater Akt 
phosphorylation [e.g.PHLDB1(118) and ClipR-59 (119)] as well Akt’s binding to CTMP 
(120) and TRB3 (121) that have been reported to favor less Akt phosphorylation.  
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Summary of results of student’s t-tests compare CR versus AL values for each 
measurement (IRTyr1162/1163, IRS-1Tyr, IRS-1-PI3K, AktThr308, AktSer473, and 2-Deoxy-D-
glucose uptake) made at each time of insulin exposure (5, 15, and 50 minutes of insulin) 
and each insulin dose (no insulin, basal, and 1.2 nM insulin).  Not significantly different, 






























Figure 4.1 2-Deoxy-D-glucose (2-DG) uptake in isolated soleus from adult rats. 2-DG 
uptake in the soleus with 0 or 1.2nM insulin. Open bars=ad libitum (AL).  Closed bars = 
calorie restriction (CR). *p<0.05, CR versus AL in the same insulin treatment group.  























Figure 4.2 Time course of IRTyr1162/1163 phosphorylation. IRTyr1162/1163 phosphorylation 
in the soleus with 0 or 1.2nM insulin at 5, 15, and 50 minutes.  Main effects on diet, 
insulin and time from 3-way ANOVA are shown. Data are means ±SEM. N=6 muscles 


























Figure 4.3 Time course of IRS-1Tyr  phosphorylation. IRS-1Tyr phosphorylation in the 
soleus with 0 or 1.2nM insulin at 5, 15, and 50 minutes.  Main effects on diet, insulin and 
time from 3-way ANOVA are shown.  Data are means ±SEM.  N=6 muscles per diet 

























Figure 4.4 Time course of IRS-1-associated PI3K Activity.  IRS-1-associated PI3K 
activity in the soleus with 0 or 1.2nM insulin at 5, 15, and 50 minutes.  Main effects on 
diet, insulin and time from 3-way ANOVA are shown. Data are means ±SEM.  N=6 




















Figure 4.5 Time course of AktThr308 and AktSer473 phosphorylation. AktThr308 and 
AktSer473 phosphorylation in the soleus with 0 or 1.2nM insulin at 5, 15, and 50 minutes.  
Main effects on diet, insulin and time from 3-way ANOVA are shown.  Data are means 









In Vivo Assessment of the Effects of Calorie Restriction on Insulin-stimulated 





The purpose of this study was to evaluate the mechanisms of in vivo insulin-
stimulated glucose uptake and phosphorylation of key insulin regulated proteins (insulin 
receptor, IR; Akt; AS160 and filamin C) in multiple skeletal muscles from adult ad 
libitum fed and CR (consuming 65% of ad libitum intake)  9mo-old Fisher 344 X Brown 
Norway rats under euglycemic-hyperinsulinemic clamp conditions.  We found that 
glucose infusion rates were 78% higher (P<0.001) in CR (31.7 ± 1.6 mg/kg-1 x min-1) 
versus AL (17.8 ± 0.8 mg/kg-1 x min-1) rats with matched plasma insulin levels (AL, 
141.3 ± 9.1 µU/ml; CR, 140.3 ± 6.7 µU/ml) thus CR leads to greater whole body insulin 
sensitivity. We evaluated four different predominantly fast-twitch (epitrochlearis, 
gastrocnemius, tibialis anterior, and plantaris) and two predominantly slow-twitch 
(adductor longus and soleus) skeletal muscles and found a significant increase in insulin-
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stimulated glucose uptake in the epitrochlearis, gastrocnemius, and tibialis anterior for 
CR versus AL rats. Phosphorylation of IR was not different between AL and CR rats in 
any muscle. The most uniform insulin signaling effect of CR compared to AL was an 
increase in insulin-stimulated Akt phosphorylation at Ser473 and Thr308 in the 
epitrochlearis, gastrocnemius, tibilais anterior, and soleus muscles. Akt Ser473 
phosphorylation alone increased for CR versus AL in the plantaris muscle however there 
was a strong statistically non-significant trend (P=0.07) for an increase at Akt Thr308. 
Adductor longus did not differ between AL and CR at either Akt phosphorylation sites. 
There was not a consistent diet effect on AS160 or filamin C phosphorylation with CR 
versus AL.  The results suggest that CR leads to greater whole body insulin sensitivity 
attributable to, at least in part, CR effects on in vivo insulin-stimulated glucose uptake by 
multiple predominantly fast-twitch skeletal muscles, but the CR effects on in vivo 
insulin-mediated glucose uptake and the associated insulin signaling mechanisms are not 
identical in all skeletal muscles. 
 
INTRODUCTION 
Calorie restriction (CR) without malnutrition (consuming ~60-75% of ad libitum, 
AL, intake) has been demonstrated to improve whole body insulin sensitivity in various 
species, including humans (40-42), non-human primates (39), rats (38) and mice (8, 37). 
Because up to 80% of insulin-stimulated blood glucose clearance is taken up by skeletal 
muscle (2), it is reasonable to expect that CR leads to increased insulin-mediated glucose 
uptake in skeletal muscle.  Supporting this idea, a number of studies using isolated mouse 
muscle (8, 37) or isolated (3-5, 9, 10, 21, 23, 24, 85, 87, 122) or perfused rat (53) skeletal 
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muscle have reported increased insulin-stimulated glucose uptake for CR versus AL 
animals.  Apparently only one publication has evaluated the effects of several months of 
CR on insulin-stimulated glucose uptake by individual rat skeletal muscles under in vivo 
conditions.  Surprisingly, the results of this study indicated that CR by 8 mo-old rats 
(consuming ~80% of AL intake beginning at 5 mo-old) did not significantly increase 
insulin-stimulated glucose uptake of  two skeletal muscles of the hind-limb  during a 
euglycemic-hyperinsulinemic clamp (93).  However, the same study reported for 24 mo-
old rats that CR (consuming ~80% of AL intake beginning at 21 mo-old) resulted in an 
increased glucose uptake by hind-limb skeletal muscles during a euglycemic-
hyperinsulinemic clamp. 
The mechanisms that account for improved CR effects on insulin-stimulated 
glucose uptake have been most frequently studied in skeletal muscle under ex vivo 
conditions.  These studies have documented that when skeletal muscle is exposed to 
insulin ex vivo, CR can enhance the effect of insulin on selected proteins in the insulin 
signaling pathway that controls the subcellular distribution of GLUT4, the insulin-
regulated glucose transporter protein.   Phosphorylation of Akt (also known as protein 
kinase B, PKB) on both Ser473 and Thr308 is essential for the full effect of insulin on 
glucose transport (8).  In this context, it is notable that the most consistent result of a 
series of studies on isolated muscles from CR versus AL rodents has been elevated 
insulin-induced phosphorylation of Akt for isolated muscles from CR rats (9, 10, 24) and 
mice (8).   Akt substrate of 160 kDa (also known as AS160 or TBC1D4) is the most 
distal substrate of Akt that has been clearly linked to insulin’s activation of GLUT4 
translocation in skeletal muscle (18, 19).  AS160 undergoes Akt-dependent 
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phosphorylation on several sites, with Thr642 and Ser588 being the sites that appear to 
account for most of insulin’s effect on glucose transport (19).   CR was recently reported 
to lead to greater insulin-mediated AS160 phosphorylation on both Thr642 and Ser588 in 
isolated epitrochlearis muscle from 9 mo-old rats (24).   
Compared to the relatively detailed information about CR effects on insulin 
signaling in muscle ex vivo, relatively few studies have focused on insulin signaling in 
rodent muscle of CR rats exposed to insulin in vivo.  Furthermore, these studies have 
focused on the effects of a supraphysiologic bolus injection of insulin rather than on 
insulin signaling in response to physiologic insulin concentrations (7, 27, 89, 123).   A 
major gap in current knowledge is the lack of any published data on the effect of in vivo 
administration of a physiologic insulin dose on insulin signaling in skeletal muscle from 
CR compared to AL rats.   
Accordingly, the first major aim of the current study was to compare adult (9 mo-
old) CR (60-65% of AL intake initiated at 3 mo-old) versus age-matched AL rats with 
regard to key insulin signaling steps (insulin receptor tyrosine phosphorylation, 
phosphorylation of Akt on Ser473 and Thr308, and phosphorylation of AS160 on Ser588 
and Thr642) in rat skeletal muscles (epitrochlearis, gastrocnemius, tibialis anterior, 
plantaris, adductor longus, and soleus) stimulated by a physiologic insulin concentration 
during a euglycemic-hyperinsulinemic clamp.  A second major goal was to measure in 
vivo glucose uptake in each of these muscles using radiolabeled 2-deoxyglucose (2DG).   
In addition, whole body insulin sensitivity was assessed based on glucose infusion rate 






Materials.  Unless otherwise noted, all chemicals were purchased from Fisher Scientific 
(Hanover Park, IL) or Sigma Chemical (St. Louis, MO). Reagents and apparatus for 
SDS-PAGE and immunoblotting were obtained from Bio-Rad Laboratories (Hercules, 
CA). Anti-phospho-AS160 Ser588 (pAS160Ser588; catalog no. 3028P2) was from B-
Bridge International (Mountain View, CA);  anti-phospho-Akt Thr308 (pAktThr308; 
catalog no. 9275), anti-phospho-Akt Ser473 (pAktSer473; catalog no. 9272 and anti-
rabbit IgG-horseradish peroxidase conjugate (catalog no. 7074) were from Cell Signaling 
Technology (Danvers, MA); Anti-phospho-IR Tyr1162/1163 (pIRTyr1162/1163; catalog 
no. 44-504G) Invitrogen (Camarillo, CA); Anti-phospho-AS160 Thr642 
(pAS160Thr642; catalog no. 07-802) and anti-sheep IgG horseradish peroxidase 
conjugate (catalog no. 12-342) were from Millipore (Billerica, MA).  West Dura 
Extended Duration Substrate (catalog no. 34075) was from Pierce (Rockford, Il).  The 
bicinchoninic acid protein assay kit (catalog no. 23227) was from Thermo Scientific 
(Rockford, Il). 
 
Animal care.  Procedures for animal care were approved by the University of Michigan 
Committee on Use and Care of Animals. Male Fischer 344 × Brown Norway, F1 
generation rats were obtained at 3 mo of age from Harlan (Indianapolis, IN). Animals 
were housed individually in shoebox cages and maintained on a 12:12-h light-dark cycle 
(lights out at 1700) in specific pathogen-free conditions. Animals had free access to food 
(Lab Diet 5053, PMI Nutritional International, Brentwood, MO) and water for a 2-wk 
acclimation period. Animals then had free access to food (NIH31 chow, Test Diet, 
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Richmond, IN) and water for another 2-wk acclimation period. During this time, food 
consumption of all rats was measured daily between 1530 and 1630 to determine baseline 
food intake (food provided minus food remaining). After the acclimation period, rats 
were ranked by weight (lowest to highest) and alternately assigned to the AL (ad libitum) 
group or the CR (calorie restricted) group, so that the initial mean weight was similar for 
both groups. After the 2-wk acclimation period, the AL group had ad libitum access to 
the NIH31 chow for the duration of the study. The CR group received NIH31/NIA 
Fortified chow (Test Diet), which contains extra vitamin supplementation to provide CR 
animals with a level of vitamins similar to that of animals allowed ad libitum access to 
the NIH31 diet. The CR group was restricted to 60–65% of the intake of the AL group 
gradually over 3 wk (90%, 75%, 60–65%). Thereafter, the CR group received 60–65% of 
the intake of the AL group daily for ∼6 mo (182–200 days). All rats were fed between 
1530 and 1630 each day, and food intake of both groups was measured daily. All rats 
were weighed weekly at the same time of day.  
 
Body composition analysis. Body fat, lean mass, and free fluid were measured using an 
NMR-based analyzer (Minispec LF90II, Bruker Optics, Billerica, MA). The 
measurements took less than 2 minutes while conscious rats were placed individually in 
the measuring tube.  
 
Surgical procedures.  AL (n=13) and CR (n=14) rats had catheters surgically placed into 
the jugular vein and carotid artery to sample blood.  All surgical instruments were 
initially autoclaved and sterilized using a hot glass bead sterilizer.  Rats were anesthetized 
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with an intraperitoneal injection of ketamine (50-90 mg/kg) and xylazine (5-10 
mg/kg).  The ventral neck and back of the head was shaved and the skin was prepared 
with 3 alternating scrubs of iodine and 70% ethanol.  Under aseptic conditions, a small 
incision was made superior to the clavicle, exposing the carotid artery and jugular 
vein.  Both vessels were catheterized and ligated in place with non-absorbable 
suture.  Catheters were tunneled subcutaneously using a 16 gauge needle and exteriorized 
at the back of the neck via stainless steel connectors that were coated with medical silicon 
and fixed subcutaneously upon the closure of the incision.  The catheters were filled with 
heparinized saline and tightly plugged with stainless steel surgical wire.  Post-
operatively, animals were placed in an isolator equipped with a heating pad for recovery. 
Ampicillin (100 mg/kg, intravenously) was given and if needed, buprenorphine (0.01-0.5 
mg/kg, subcutaneously) for pain every 8-12 h.  Warm ringers solution was given to 
replace lost fluids (1 ml/100 g bw/h surgery). 
 
Procedures for euglycemic hyperinsulinemic clamp (clamp).  At approximately 0800 on 
the morning of clamp experiments, food was removed from rats (~5 h prior to the start of 
the clamp and infusion procedures).  The clamp protocol consisted of a 120 min 
experimental clamp period (t = 0 to 120 min). At t = -10 min, a blood sample (~100 μl) 
was taken from the arterial catheter for assessment of basal levels of insulin and glucose. 
The insulin infusion was begun at t = 0 with a primed-continuous infusion of human 
insulin (Novo Nordisk).  Euglycemia (120-130 mg/dL) was maintained during the clamp 
by measuring blood glucose every 10 min starting at t = 0 and infusing 50% glucose at 
variable rates accordingly. Blood insulin concentrations were determined from samples 
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taken at t = -10 and 120 min.  Insulin infusion rates were selected with the goal of 
achieving similar plasma values for insulin in the CR group compared to the AL group. 
We have previously reported that CR rats compared to AL rats have higher C-peptide-to-
insulin ratio suggesting that insulin clearance is greater for CR animals (22). Others have 
reported that CR versus AL that were injected with [125I]-insulin have greater hepatic 
binding of insulin (124, 125).  Therefore, to achieve similar plasma insulin in CR and AL 
rats, insulin was infused at a higher rate for CR rats (4.7 to 6.0 mU·kg-1·min-1) versus AL 
rats (4.0 mU·kg-1·min-1).  The insulin fusion rate for AL rats was 4.0 mU/kg/min, and 
insulin-infusion rate for CR rats was 4.7 to 6.0 mU/kg/min.    
 
Blood and plasma analysis.  Blood glucose during clamps was measured using an Accu-
Chek glucometer (Roche, Germany). Plasma insulin was measured using  Linco 
rat/mouse insulin ELISA kits.  For determination of plasma radioactivity of [1-14C]2DG, 
plasma samples were deproteinized with zince sulfate (0.3N) and barium hydroxide 
(0.3N) and counted using a Liquid Scintillation Counter (Beckman Coulter LS6500 
Multi-purpose Scintillation Counter) (126-128).  
 
Skeletal muscle glucose uptake. To estimate glucose uptake in skeletal muscle, a bolus 
injection of [1-14C]-2-deoxyglucose ([14C]2DG; PerkinElmer) was given at t = 120 min 
while continuously maintaining the hyperinsulinemic-euglycemic steady-state.  At the 
end of the experiment, skeletal muscles (epitrochlearis , gastrocnemius, tibialis anterior, 
plantaris, adductor longus, and soleus) were collected and immediately frozen in liquid 
nitrogen.  A portion of each muscle was used for later analysis of muscle [14C]2DG-6-
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phosphate ([14C]2DG6P).  Muscles used for this analysis were homogenized in 0.5% 
perchloric acid and centrifuged at 2,000g for 15 min at 4°C.  The supernatants were 
neutralized with potassium hydroxide (5N).  An aliquot of the homogenate was 
quantified by liquid scintillation counting (Perkin Elmer TRI-CARB 2800TR 
Scintillation Counter) to determine total tissue values (disintegrations per minute,dpm)   
for the sum of [14C]2DG and [14C]2DGP.   Another aliquot was deproteinized with zinc 
sulfate (0.3N) and barium hydroxide (0.3N) to precipitate the [14C]2DG6P and quantify 
[14C]2DG in the supernatant.  The value for the [14C]2DG in the supernatant (dpm) was 
subtracted from the total tissue [14C]2DG and [14C]2DGP (dpm) to calculate the glucose 
uptake rate as indicated by the skeletal muscle [14C]2DGP  accumulation.  Another 
aliquot of muscle homogenate was used to determine total protein concentration using the 
bicinchoninic acid protein assay kit, and the glucose uptake value was expressed relative 
to muscle total protein concentration (126-128).  
 
 Immunoblotting.  Equal amounts of protein from each sample were mixed with 6× 
Laemmli buffer, boiled with SDS loading buffer for 5 min, separated by 10% SDS-
PAGE, and then transferred to nitrocellulose.  Membranes were rinsed with Tris-buffered 
saline plus tween (TBST; 0.14 mol/l NaCL, 0.02 mol/l Tris base, pH 7.6, and 0.1% 
Tween), blocked with 5% bovine serum albumin (BSA) in TBST for 1 h at room 
temperature and transferred to primary antibody 1:1000 in TBST plus 5% BSA overnight 
at 4°C.  Blots were washed 3 x 5 min with TBST and incubated in buffer containing the 
appropriate secondary antibody (1:20,000 dilution) for 1 h at room temperature.  
Membranes were then washed 3 x 5 min with TBST and subjected to enhanced 
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chemiluminescence for visualization of protein bands. Immunoreactive proteins were 
quantified by densitometry (AlphaEase FC, Alpha Innotech, San Leandro, CA).   
 
Statistical analyses.   Data were analyzed using SigmaPlot, version 11.0 (SPSS, San Jose, 
CA).  Student’s t-test was used for comparisons between two groups (i.e., AL versus CR 
for glucose infusion rate, body mass and body composition measurements).   Data are 
presented as mean ± SEM.  A p value ≤ 0.05 was accepted as statistically significant. 
 
RESULTS   
Body Mass, Body Composition, Blood Glucose, and Blood Insulin 
  Body mass was greater (P < 0.05) in the AL (417.4 ± 9.4 g) versus CR (274.3 ± 
4.3 g) rats. Body fat percentage was greater (P < 0.05) for AL (15.4 ± 0.5%) versus CR 
(7.1 ± 0.6%) rats. Lean body mass percentage was greater (P < 0.05) in the CR (78.1 ± 
0.4%) versus AL (70.0 ± 1.4%) rats. The fluid percentage was not different between AL 
(7.6 ± 0.2%) and CR (7.9 ± 0.1%). The fasting blood glucose was not significantly 
different between AL (106.5 ± 2.7 mg/dl) and CR (100.9 ± 4.24mg/dl) (P=0.28).  Fasting 
insulin levels were greater (P < 0.005) for AL (53.7 ± 5.6 µU/ml) versus CR (28.3 ± 4.5 
µU/ml) rats. 
 
Euglycemic-Hyperinsulinemic Clamp   
Glucose levels during the clamp were maintained at 120.7 ± 2.7 mg/dl for AL and 
126.1 ± 2.4 mg/dl CR.  Insulin levels during the clamp were similar for AL (141.3 ± 9.1 
µU/ml) and CR (140.3 ± 6.7 µU/ml).   Glucose infusion rates were 78% higher (P<0.001) 





Epitrochlearis 2-DG uptake was significantly greater (P < 0.05) for CR versus AL 
rats.  In the gastrocnemius, 2-DG uptake increased (P < 0.05) in CR versus AL rats.  Also 
in the tibialis anterior 2-DG uptake was significantly increased (P < 0.05) for CR versus 
AL rats. There were no significant diet effects for 2-DG uptake between AL and CR rats 
in the plantaris, adductor longus, or soleus muscles. (Figure 5.1) 
 
Insulin Receptor Phosphorylation 
 There were no significant diet effects on IR (insulin receptor) Tyr1162/1163 
phosphorylation between AL and CR rats in the epitrochlearis, gastrocnemius, tibalis 
anterior, plantaris, adductor longus, or soleus (Figure 5.2).  
 
Akt Phosphorylation  
In the epitrochlearis, Akt phosphorylation increased in CR versus AL rats at both 
the Thr308 (P<0.05) and Ser473 sites (P<0.05).  For the gastrocnemius, Akt 
phosphorylation for CR versus AL rats was increased at the Ser473 site (P<0.05) and 
increased at the T308 site (P=0.05) with CR versus AL rats. There were significant 
increases in Akt phosphorylation in the CR versus AL rats in the tibialis anterior at both 
Thr308 (P=0.05) and Ser473 (P<0.05). In the plantaris, Akt phosphorylation increased in 
CR versus AL at the Ser473 site (P<0.05) and tended to increase at the Thr308 site 
(P=0.07). There were no significant diet effects on Akt phosphorylation at either site in 
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the adductor longus muscle. In the soleus, Akt phosphorylation increased for CR versus 
AL at both the Thr308 (P<0.05) and Ser473 (P<0.05) sites (Figure 5.3 and 5.4). 
 
AS160 Phosphorylation 
In the epitrochlearis of CR versus AL rats, AS160 phosphorylation tended to 
increase at the Thr642 site (P=0.08) and increased at the Ser588 site (P<0.05). In the 
gastrocnemius, AS160 phosphorylation at the Thr642 site or the Ser588 site did not 
change significantly with diet. In the tibialis anterior of CR versus AL rats, AS160 
phosphorylation increased at both the Thr642 (P<0.05) and Ser588 (P<0.05) sites. In the 
plantaris, AS160 phosphorylation did not increase at the Thr642 site and tended to 
increase (P=0.06) at the Ser588 site.  In the adductor longus, AS160 phosphorylation at 
the Thr642 site or the Ser588 site did not change significantly with diet. In the soleus, 
AS160 phosphorylation increased at the Thr642 site (P<0.05) and did not change at the 
Ser588 site (Figure 5.5 and 5.6). 
 
Filamin C Phosphorylation 
In the plantaris of CR versus AL rats, filamin C phosphorylation at the Ser2213 
site increased (P<0.05).  There were no significant diet effects on filamin C Ser2213 
phosphorylation in the epitrochlearis, gastrocnemius, tibalis anterior, adductor longus, or 





Our research group has previously shown that CR can enhance insulin-stimulated 
glucose uptake in skeletal muscle under ex vivo conditions (3, 8-10, 21, 24, 25, 85-87, 
114). The current study is the first to look at the effects of CR on in vivo glucose uptake 
by skeletal muscle together with the associated insulin signaling events.  We determined 
glucose uptake and phosphorylation of key insulin signaling proteins in AL and CR rats 
with insulin levels elevated to similar physiologic levels in both diet groups. We 
evaluated four different predominantly fast-twitch (epitrochlearis, gastrocnemius, tibialis 
anterior, and plantaris) and two predominantly slow-twitch (adductor longus and soleus) 
skeletal muscles (81) and found a significant increase in insulin-stimulated glucose 
uptake in three out of six skeletal muscles studied.  There was increased 2-DG uptake in 
the epitrochlearis, gastrocnemius, and tibialis anterior for CR versus AL rats and no 
significant difference between diet groups for plantaris, adductor longus, and soleus. We 
evaluated the most proximal insulin signaling protein, the insulin receptor (IR).  
Phosphorylation of IR was not different between AL and CR rats. The most consistent 
effect of CR compared to AL was a robust increase in insulin-stimulated Akt 
phosphorylation. We looked at the two important sites on Akt (Ser473 and Thr308) that 
are phosphorylated upon activation by insulin, and we found an increase with CR versus 
AL at both sites in the epitrochlearis, gastrocnemius, tibilais anterior, and soleus muscles. 
Akt Ser473 phosphorylation alone increased for CR versus AL in the plantaris muscle 
however there was a strong statistically non-significant trend (P=0.07) for an increase at 
Akt Thr308. Adductor longus did not differ between AL and CR at either Akt 
phosphorylation sites. AS160 is an Akt substrate and the most distal insulin signaling 
protein that is linked to insulin-stimulated glucose uptake in skeletal muscle. We found 
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that AS160 (Thr642 and Ser588) phosphorylation was increased with CR versus AL in 
the epitrochlearis and tibialis anterior. AS160 phosphorylation increased only at Thr642 
in the soleus muscle and in the plantaris had a statistically non-significant trend to 
increase only at Ser588 (P=0.06). We found no evidence for an increased AS160 
phosphorylation in the gastrocnemius or adductor longus. Filamin C is a highly expressed 
protein in skeletal muscle (129)  and believed to be involved with stabilizing actin 
filament structures (130). Actin filaments have been implicated to play a role with the 
insulin-mediated regulation of GLUT4 transporter vesicle movement (131) but the 
possible functional significance of filamin C for GLUT4 translocation has not been 
tested.  Filamin C was previously identified as an Akt substrate that is phosphorylated on 
Ser2213 in insulin-stimulated C2C12 myocytes (129).  Interestingly, it has been 
demonstrated that the CR-related increase in activation of Akt is accompanied by greater 
phosphorylation of filamin C on Ser2213 in rat skeletal muscle (Sharma, Arias, Sequea 
and Cartee, unpublished results). In the current study, in vivo filamin C phosphorylation 
on Ser2213 increased with CR versus AL only in the plantaris muscle. 
Using the euglycemic-hyperinsulinemic clamp, we demonstrated that overall 
insulin sensitivity is increased with calorie restriction in the FBN rat.  In a previous 
publication, Escriva et al. (93) also found that rats that were calorie restricted had higher 
glucose disposal rates indicating that calorie restriction increased whole body insulin 
sensitivity.   Earlier studies using the euglycemic clamp had also found calorie restriction 




Escriva et al. also measured muscle-specific glucose disposal in the soleus and 
quadriceps femoris from 8 mo-old rats and reported that CR did not significantly increase 
in vivo insulin-stimulated glucose uptake in either of these muscles.  The results for the 
soleus are reminiscent of the current study where we found that glucose uptake was also 
not increased in the soleus.   We also found no evidence for CR to increase glucose 
uptake by the adductor longus, which has been reported to have a fiber type composition 
(90% type I and 10% type II) similar to the soleus (88% type I and 12% type II) (81).  
The quadriceps femoris is a predominantly fast-twitch muscle (2% type I and 98% type 
II).  In our study we found a significant CR versus AL effect in glucose uptake in three 
predominantly fast-twitch muscles:  the epitrochlearis (8% type I and 92% type II), 
gastrocnemius (10% type I and 90% type II), and tibialis anterior (1% type I and 99% 
type II) muscles, but not in the predominantly fast-twitch plantaris (4% type I and 96% 
type II).  It is not clear why there was no significant CR result in the quadriceps femoris  
and plantaris muscles compared to the significant CR effect on 3 of 4 predominantly fast-
twitch muscle in the current study, but it is possible that a similar reason is relevant for 
the lack of a detectable CR effect on the quadriceps and the plantaris.   Other important 
differences between the experiment by Escriva et al. versus the current study include:   
difference in strain (Wistar versus Fischer Brown Norway), the duration (3 months versus 
6 months) and degree (80% versus 65% of AL intake) of calorie restriction, or 
differences in the clamp procedures.   The euglycemic-hyperinsulinemic clamp of Escriva 
et al. was conducted with anesthetized rats in which the surgery was performed 
immediately prior to the clamp whereas in the current study rats were conscious 
throughout the clamp procedure and the surgery was performed 7 days prior to the clamp.   
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In spite of these differences in experimental design and methods, the similarity between 
the key results for CR effects on glucose uptake in 8-9 mo-old rats is notable (greater 
whole body insulin sensitivity, lack of a significant effect on the soleus, and the lack of a 
significant effect on at least one predominantly fast-twitch muscle). 
Although there is very limited literature regarding the effect of CR on glucose 
uptake in rodents in skeletal muscles in vivo, many previous studies have documented 
CR-induced increases in insulin-stimulated glucose uptake by isolated skeletal muscle ex 
vivo (3, 8-10, 21, 24, 25, 85-87, 114).  A recent study from our group evaluated ex vivo 
glucose uptake by epitrochlearis and soleus muscles from rats that undergone the same 
treatment as the current study.  In isolated skeletal muscle, male 9-mo old FBN rats with 
the same feeding protocol as the rats used in the current study, showed epitrochlearis 
(predominantly fast-twitch) from CR versus AL rats result in enhanced glucose uptake. In 
this study the predominantly fast-twitch epitrochlearis muscle showed an increase in 
glucose uptake for CR versus AL. The isolated soleus (predominantly slow-twitch) 
muscle from CR versus AL rats had enhanced glucose uptake, however in this study the 
soleus did have a significant increase for insulin-mediated glucose uptake with CR versus 
AL. It is notable that in the ex vivo experiment the epitrochlearis had a relatively higher 
increase in glucose uptake with CR compared to the soleus muscle (61% versus 40%) 
(24).  Although there was not a significant CR effect on in vivo glucose uptake in the 
soleus, there was a non-significant trend (P=0.26) for 19% greater values for the CR 
versus AL group.  Escriva et al. (93) also found a non-significant trend for ~48% greater 
glucose uptake by the soleus of CR compared to rats.  The lack of a significant CR effect 
on glucose uptake in the soleus may be explained by a difference in ex vivo versus in 
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vivo conditions.  Differences between the in vivo and ex vivo condition that may 
influence glucose uptake include but are not limited to: 1) the influence of blood flow, 2) 
presence of circulating hormones and cytokines (i.e. adiponectin, resistin, leptin, 
cortiscosterone, etc.) 3) circulating fuels (free fatty acids, amino acids and glucose), and 
4) neural recruitment and contractile activity of skeletal muscles.  Skeletal muscle 
glucose uptake, in addition to intrinsic mechanisms in the muscle itself, is regulated by 
extrinsic factors such as blood flow.   
An increase in blood flow delivers more glucose and insulin to skeletal muscle 
which increases the insulin-stimulated glucose uptake (132).  Calorie restriction of obese 
humans has been shown to increase skeletal muscle blood flow with an insulin infusion 
(133). In obese, insulin resistant OLETF rats, CR for 8 weeks led to improved whole 
body insulin sensitivity without detectable effects on insulin-induced vasodilation of 
isolated microvascular preparations from the red or white gastrocnemius muscles (134).   
We are not aware of any evidence that muscle blood flow is reduced by calorie restriction 
in rats, and seem an unlikely explanation of why there was not a significant CR effect on 
insulin-stimulated glucose uptake in the soleus in vivo.  Circulating blood cytokines have 
been shown to influence insulin sensitivity and may affect in vivo insulin-mediated 
glucose uptake.  Adiponectin and leptin have been shown to increase insulin sensitivity 
and conversely resistin has been shown to decrease insulin sensitivity (135).  In 8 mo-old 
rats, fasting plasma adiponectin was shown to increase significantly while plasma leptin 
and plasma resistin significantly decreased in CR versus AL rats (93).  Increased 
adiponectin and decreased resistin would favor increased insulin sensitivity and increased 
insulin-stimulated glucose uptake and thus would not adequately explain the soleus 
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muscle result. However, decreased circulating leptin levels is a plausible factor that 
would favor reduced insulin sensitivity and subsequent insulin-stimulated glucose uptake 
thus blunting insulin-stimulated uptake in the soleus in vivo relative to ex vivo 
conditions.   Physiological concentrations of corticosterone was shown to have no effect 
on insulin-stimulated glucose uptake and only supraphysiological levels of corticosterone 
decreased 2DG uptake  in soleus and extensor digitorum longus muscles (136).  
Corticosterone has been shown to increase with CR versus AL in rats (137, 138), but 
physiologic levels of corticosterone would not be expected to alter the in vivo insulin-
stimulated uptake in the soleus.  
Philip Randle described the reciprocal relationship between the oxidation rates of 
lipids and carbohydrates (called the Glucose Fatty Acid Cycle), and demonstrated that 
this relationship can be influenced by extracellular concentrations of free fatty acids 
(139). Plasma free fatty acids have been shown to decrease with CR in old rats during a 
clamp (140). If plasma free fatty acids were lower in CR rats, it would not be expected to 
reduce glucose uptake in muscle.   
In this study, we reported that fasting plasma glucose was not significantly 
different between CR and AL rats and a similar observation was also reported previously 
(93) in another study.  High rates of glucose uptake by muscle during the clamp could 
lead to an increase conversion of glucose-6-phosphate (G-6-P) if hexokinase could not 
keep pace with the high glucose entry  into the muscle via the greater insulin-stimulated 
translocation of the GLUT4 transporter that has been reported for muscles of CR rats (3).  
Accumulation of G-6-P can exert end-product inhibition on hexokinase leading to 
accumulation of free glucose within the muscle which would subsequently result in 
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counter-transport of glucose and decreased net glucose uptake measured in vivo relative 
to ex vivo in the absence of glucose.  Although plasma glucose was matched between diet 
groups during the clamp, glucose was not included during the 50 minutes of ex vivo 
incubation of muscles. When the glucose analog that was present ex vivo (2-
deoxyglucose, 2-DG) is phosphorylated to 2-DG-6-P, unlike G-6-P, it is not a potent 
inhibitor of hexokinase (110).   It should also be noted that the measurement of glucose 
uptake in vivo versus ex vivo was not identical. Ex vivo glucose uptake measurements 
included total 2-DG and 2-DG-6-P as described previously (110, 141), whereas in vivo 
glucose uptake measured the accumulation of 2-DG-6-P only as described above. 
Measuring only 2-DG-6-P would be expected to be lower than 2DG plus 2-DG-6-P if 
hexokinase were rate-limiting.   
Skeletal muscle in vivo maintains physiological neural inputs and recruitment 
patterns during the course of experimentation.  The soleus muscle is a predominantly 
slow-twitch, postural muscle and is likely recruited for contraction while the conscious 
rat is standing during the clamp procedure in this study. Increased contraction would 
seem to favor an insulin-independent increase in skeletal muscle glucose uptake and 
would increase the in vivo glucose uptake observed in the soleus.  Some studies have 
suggested small differences in spontaneous physical activity of CR versus AL rats, with 
the greatest differences evident near the time when CR rats are fed (142).  Physical 
activity was not systematically monitored during the clamps, but neither group was 
noticed to have high levels of activity, and there were not obvious differences between 
groups.  There does not appear to be a compelling reason to expect that in vivo 
91 
 
recruitment of the soleus muscle would likely explain why there was no significant 
increased insulin-mediated glucose uptake in vivo when compared to the soleus ex vivo.   
Other notable differences between the in vivo and ex vivo conditions in our 
experiment are the dosage and duration of insulin stimulation. The insulin concentration 
in vivo (~140 µU/ml) versus ex vivo (200 µU/ml) was similar but not identical. We do 
not expect this  small difference in insulin concentration to play a significant role in the 
skeletal muscle glucose accumulation but it is possible the lower insulin dosage in vivo 
could have accounted for the lower insulin-stimulated glucose uptake in the soleus in 
vivo relative to ex vivo.   The duration of insulin stimulation during the clamp was 
approximately 120 minutes compared to 50 minutes with ex vivo incubations.  It is 
possible that the longer exposure of insulin may have caused inhibition via the insulin 
signaling pathway in vivo versus ex vivo, which would favor decreased insulin-
stimulated glucose uptake as was seen in the soleus in vivo versus ex vivo.    
Taking together results for CR effects on insulin-stimulated glucose uptake in 
skeletal muscle under both in vivo and ex vivo are powerful because in combination these 
methods provide greater insights into the mechanisms by which CR increases insulin 
sensitivity in skeletal muscle than would not be evident using only one of the approaches.  
Ex vivo incubations allow greater experimental control for investigating the intrinsic 
ability of the muscle to respond to insulin and CR without the influence of blood flow, 
neural inputs, and blood-borne chemokines.  In vivo experimentation is advantageous 
because insulin-stimulated glucose uptake measurements are taken in a physiological 
context.  The influence of usual-living insulin levels, blood flow, neural inputs, and blood 
chemokines may influence CR’s effects on skeletal muscle.  In combination, the results 
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from ex vivo and in vivo experimentation give us the most comprehensive view of the 
CR effects on insulin-stimulated glucose uptake in skeletal muscle to date. 
Phosphorylation of IR was not different between AL and CR rats. This result is 
consistent with a number of prior experiments examining the phosphorylation state of the 
IR with CR versus AL with physiologic insulin. In studies analyzing ex vivo CR effect in 
rats, there was also no difference in insulin receptor phosphorylation between AL and CR 
muscles incubated with a physiologic insulin dose (24, 114). Published studies that have 
previously reported increased insulin receptor phosphorylation in vivo with CR used a 
supraphysiologic dose of insulin via a bolus injection (6, 27).  
To our knowledge Akt phosphorylation with CR has not been studied with 
physiologic insulin in a clamp study.  The CR-mediated increase for Akt phosphorylation 
is very similar to results ex vivo with similar aged rats fed with the exact protocol as the 
current study.  Sharma et al. (24) found that CR significantly increased Akt 
phosphorylation versus AL fed rats at both the Thr308 and Ser473 sites. Other studies 
have also seen similar increases in CR for Akt phosphorylation in rats ex vivo (9, 10, 
114).   In the current study, Akt phosphorylation was increased in the epitrochlearis, 
gastrocnemius, tibialis anterior, plantaris, and soleus muscles, with only the adductor 
longus not having a significant increase.  Of all of the insulin signaling measurements 
made in this and previous studies, Akt phosphorylation has been most consistently 
increased with CR versus AL animals, both in vivo and ex vivo.  
There are no other reports on phosphorylation of AS160 with calorie restriction 
on insulin-stimulated muscles in vivo.  In 9 month old rat epitrochlearis muscle incubated 
ex vivo with physiological insulin there was an increase in the phosphorylation of AS160 
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at both Thr642 and Ser588 sites. Three out of four (epitrochlearis, tibialis anterior, and 
plantaris) predominantly fast-twitch muscles in the current study increased in at least one 
AS160 phosphorylation site.  In 9 month old rat soleus muscle incubated with 
physiological insulin there was no increase in the phosphorylation of AS160 with CR 
versus AL, and in this study, the soleus muscle had increased phosphorylation at Thr642 
but not Ser588 with CR versus AL.  In another study of isolated epitrochlearis and soleus 
muscle from 24 mo-old rats incubated in physiological insulin there was no increase in 
AS160 phosphorylation with CR versus AL in either muscle (114).  In the current study, 
there was also no increase for AS160 phosphorylation in either the adductor longus or 
gastrocnemius.  In summary, although the CR effect on AS160 phosphorylation appeared 
to be generally similar for the epitrochlearis of 9 month-old rats under both in vivo and ex 
vivo conditions, greater AS160 phosphorylation with CR versus AL was not uniformly 
found in all muscles in either condition.   
In 9 month old rat epitrochlearis muscle incubated with physiological insulin 
there was an increase in the phosphorylation of filamin C on Ser2213 (Sharma et al, 
unpublished results). Also in 24 month-old rat epitrochlearis and soleus muscle incubated 
with physiological insulin there was an increase in the phosphorylation of filamin C on 
Ser2213 (Sequea, Sharma, Arias and Cartee, unpublished results).  The current study was 
the first to report CR effects on filamin C phosphorylation on Ser2213 in muscle 
collected after in vivo insulin treatment.   The only significant increase for CR versus AL 
was in the plantaris muscle.  The current data indicate that, in contrast to results for 
muscles studied ex vivo, greater filamin C phosphorylation is not a typical result for CR 
versus AL muscles stimulated with insulin in vivo. 
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Taking together the results for glucose uptake and insulin signaling in five 
different muscles offers an opportunity to probe for insights into possible mechanisms for 
CR-related benefits on insulin sensitivity in muscle.  For CR versus AL rats, in vivo 
glucose uptake was significantly greater in the predominantly fast-twitch epitrochelaris, 
gastrocnemius, and tibialis anterior muscle.  In each of these muscles, the CR-mediated 
increase in glucose uptake occurred independent of a diet effect on insulin receptor 
activation together with an increase in Akt phosphorylation.   A number of previous 
studies have consistently reported a CR-associated increase in muscle Akt 
phosphorylation concomitant with greater insulin-stimulated glucose uptake (8-10, 24, 
114).  However, in the current study, the CR-related increases in Akt phosphorylation in 
the soleus and plantaris muscles were not accompanied by significantly increased glucose 
uptake.   Neither Akt phosphorylation nor glucose uptake was significantly increased in 
the adductor longus muscle of CR versus AL rats. Taken together, these results suggest 
that the CR-induced increase in Akt activation by greater phosphorylation on Ser473 and 
Thr308 may be necessary, but not sufficient for greater in vivo insulin-stimulated glucose 
uptake of CR versus AL rats.  There is not a simple relationship between CR effects on 
glucose uptake and AS160 phosphorylation.  For two (epitrochlearis and tibialis anterior) 
of the three muscles characterized by greater in vivo glucose uptake in CR compared to 
AL rats, AS160 phosphorylation on at least one site was also greater for CR rats.  
However, there was not a consistent relationship between CR effects on AS160 
phosphorylation and in vivo glucose uptake in the gastrocnemius (only glucose uptake 
increased with CR) or the soleus (only phosphorylation of Ser588 increased with CR).  
Under ex vivo conditions in 9 month-old rats, both the epitrochlearis and soleus were 
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characterized by CR-related improvements in glucose uptake, but only in the 
epitrochlearis was AS160 phosphorylation greater for CR versus AL rats. Taking together 
the ex vivo results from previous research and the in vivo results from the current study, 
it is apparent that CR effects on insulin-stimulated glucose uptake in the soleus are not 
attributable to CR effects on AS160 phosphorylation on Thr642 or Ser588.  There was no 
correspondence between CR effects on in vivo glucose uptake and filamin C 
phosphorylation.  Based on the current results, the strongest link between CR effects on 
insulin signaling and glucose uptake are found with greater Akt phosphorylation that is 
usually observed for CR compared to AL muscles.  However, the important intermediate 
steps between CR effects on Akt and glucose uptake are uncertain.  Regulation of in vivo 
glucose uptake by AS160 and filamin C may be regulated on other Akt-phosphorylation 
sites not measured in this study.  There may be CR effects on AS160 or filamin C that are 
localized to certain subcellular regions and not evident when analyzing the whole muscle 
lysate.  It is also possible that other unknown Akt substrates may play a role in regulating 
CR’s effect on glucose uptake.   It also remains possible that CR can influence glucose 
uptake by Akt-independent mechanisms.    
Regardless of the possible role of different insulin signaling steps for CR effects 
on glucose uptake, another important issue is to understand how CR effects on the 
different insulin signaling steps are related to each other.  There was no effect of CR on 
the insulin receptor tyrosine phosphorylation on 1162/1163 observed in any muscle, so 
other mechanisms must account for the CR effects on post-receptor signaling.  We 
reported that Akt phosphorylation was increased with CR in five out of six muscles and 
was the most consistent effect of CR. The increase in Akt phosphorylation did not appear 
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to be a result of increased upstream insulin receptor activation.  We did not find a 
uniform predicative relationship between Akt phosphorylation and AS160 
phosphorylation with CR versus AL. Only in the tibialis anterior did phosphorylation on 
both Akt sites lead to phosphorylation on both AS160 phosphorylation sites. There was 
increased AS160 phosphorylation in the epitrochlearis, plantaris, and soleus on only one 
out of two phosphorylation sites despite an increase for both Thr308 and Ser473 on Akt. 
The adductor longus muscle consistently lacked a diet effect for CR versus AL for the 
insulin signaling molecules in which we studied.  AS160 phosphorylation with CR versus 
AL was not increased seemingly because there was no increase in the upstream Akt 
phosphorylation in the adductor longus muscle. It is not clear why the gastrocnemius did 
not have an increase for AS160 phosphorylation despite an increase in Akt 
phosphorylation.  Similarly, there were no significant diet effects for Ser2213 
phosphorylation on filamin C in the epitrochlearis, gastrocnemius, tibialis anterior, or 
solelus despite an increase in Akt phosphorylation in these muscles.  Only in the plantaris 
muscle did an increase in Akt phosphorylation coincide with an increase in filamin C 
phosphorylation.  The ability of a kinase to phosphorylate substrates depends heavily on 
proximity.  In some cases, the subcellular localization of AS160 and filamin C may not 
be accessible for activated Akt and may explain why we found a diet effect on Akt but 
not known Akt substrates in some muscles.  In addition, although an increase for total 
Akt phosphorylation does not lead to an increase for AS160 and filamin C 
phosphorylation, the Akt2 specific isoform may be a better predictor of AS160 and/or 
filamin C phosphorylation. 
97 
 
In conclusion, the current data demonstrate that CR leads to greater whole body 
insulin sensitivity that is, at least in part, attributable to substantial CR effects on in vivo 
insulin-stimulated glucose uptake by multiple predominantly fast-twitch skeletal muscles.  
The current results also clearly demonstrate that CR does not uniformly enhance insulin-
stimulated glucose uptake in all skeletal muscles.  Although CR did not significantly 
enhance in vivo glucose uptake in either predominantly slow-twitch muscle that was 
studied, there was also no evidence for a CR effect on glucose uptake by the 
predominantly fast-twitch plantaris.  The results support the idea that CR effects on 
glucose uptake are, at least in part, related to enhancing Akt phosphorylation.  However, 
the current results indicate that CR effects on neither AS160 (Thr642 and Ser588) 
phosphorylation nor filamin C Ser2213 phosphorylation are essential for greater glucose 
uptake in skeletal muscle.  This result implies that the signaling mechanisms for CR 
enhanced insulin-mediated glucose uptake are not identical in all skeletal muscles and 
increased Akt phosphorylation does not simply translate to increase phosphorylation of 
AS160 and filamin C.  Future studies will be necessary to fully determine the precise role 
of CR on in vivo glucose uptake and the insulin signaling mechanisms in skeletal muscle.   
Assessing the effect of CR on Akt-binding proteins in vivo may provide insight into how 
Akt may be regulated with CR.  Further, identifying other insulin-regulated Akt 
phosphorylation sites on AS160, filamin C, and other known Akt substrates (e.g. 
TBC1D1 and CDP-138) may elucidate the links between CR effects on Akt 
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Figure 5.1 In Vivo 2-Deoxy-D-glucose (2-DG) uptake. 2-DG uptake in epitrochlearis 
(A), gastrocnemius (B), tibialis anterior (C), plantaris (D), adductor longus (E), and 
soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus AL.  Data are 






Figure 5.2 In vivo insulin receptor tyrosine phosphorylation (IRTyr1162/1163). 
IRTyr1162/1163 phosphorylation in epitrochlearis (A), gastrocnemius (B),  tibialis anterior 
(C), plantaris (D), adductor longus (E), and soleus (F) muscles in AL and CR treated 




Figure 5.3 In vivo AktSer473 phosphorylation. AktSer473 phosphorylation in epitrochlearis 
(A), gastrocnemius (B), tibialis anterior (C), plantaris (D), adductor longus (E), and 
soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus AL.  Data are 





Figure 5.4 In vivo AktThr308 phosphorylation. AktThr308 phosphorylation in 
epitrochlearis (A), gastrocnemius (B), tibialis anterior (C), plantaris (D), adductor longus 
(E), and soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus AL.  Data 





Figure 5.5 In vivo AS160Thr642 phosphorylation. AS160Thr642 phosphorylation in 
epitrochlearis (A), gastrocnemius (B), tibialis anterior (C), plantaris (D), adductor longus 
(E), and soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus AL.  Data 




Figure 5.6 In vivo AS160Ser588 phosphorylation. AS160Ser588 phosphorylation in 
epitrochlearis (A), gastrocnemius (B), tibialis anterior(C), plantaris (D), adductor longus 
(E), and soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus AL.  Data 




Figure 5.7 In vivo Filamin CSer2213 phosphorylation. Filamin CSer2213 phosphorylation 
in epitrochlearis (A), gastrocnemius (B), tibialis anterior(C), plantaris (D), adductor 
longus (E), and soleus (F) muscles in AL and CR treated groups.  *p<0.05, CR versus 









Focus of this Discussion 
 This chapter of the dissertation will first summarize the major new results of 
Studies 1 to 3.  A concise summary of the results from the three studies in this 
dissertation is provided in Table 6.1 (page 124).   The chapter will also provide a brief 
discussion that integrates the insights gained by considering together the novel results 
from each study to extend our current understanding of CR-related increase on insulin-
stimulated glucose uptake by sequentially addressing the novel insights from this 
dissertation with regard to CR effects on:  insulin signaling proximal to Akt, activation of 
Akt, phosphorylation of Akt substrates, and glucose uptake.  This discussion will also 
identify some of the key issues for future research that these studies brought to the 
forefront.  The final section of this discussion will focus on how the contributions from 
the research included in the dissertation have provided a unique and important new 
perspective to understanding the influence of CR on insulin signaling and glucose uptake 




Summary of Key Findings 
Results from this dissertation provide novel insights into fully understanding the 
mechanisms that account for enhanced insulin-stimulated glucose transport with calorie 
restriction (CR).  Study 1 provided the first data on the effects of CR in old age on insulin 
signaling and glucose uptake in skeletal muscle with a physiologic insulin dose.  Results 
from Study 2 evaluated the possibility that CR results in a transiently greater insulin-
mediated activation in skeletal muscle of key insulin signaling that are proximal to Akt.  
Study 3 extended the observations based on evaluation of four predominantly fast-twitch 
and two predominantly slow-twitch skeletal muscles in vivo by probing CR effects on 
insulin-stimulated glucose uptake and insulin signaling in an in vivo model.  A bulleted 
summary of the key findings is provided below.  
 
Study 1: Calorie Restriction Enhances Insulin-stimulated Glucose Uptake and Akt 
Phosphorylation in Both Fast-twitch and Slow-twitch Skeletal Muscle of 24 Month-
old Rats 
 In male 24 mo-old Fisher 344 Brown Norway rats, CR (6 mo duration) 
glucose uptake was enhanced for both the insulin-stimulated soleus (primarily 
type I fibers) and epitrochlearis (primarily type II fibers). 
 GLUT4 abundance was unchanged by CR in the soleus and epitrochlearis. 
 Insulin receptor phosphorylation was not altered by diet in either soleus or 
epitrochlearis either with or without insulin.  
 Akt phosphorylation on Thr308 and Ser473 was enhanced in the insulin-
stimulated soleus and epitrochlearis.  
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 AS160 phosphorylation at Thr642 and Ser588 was unchanged by diet in the 
soleus and epitrochlearis either with or without insulin.  
 TBC1D1 phosphorylation at Thr596 was unchanged by diet in both soleus and 
epitrochlearis either with or without insulin.  
 Filamin C phosphorylation at Ser2213 was greater for CR versus AL rats in 
the insulin-stimulated soleus and epitrochlearis. 
 
Study 2: Comparison of Ad Libitum Fed and Calorie Restricted Rats for the Time 
Course of Insulin’s Activation of Signaling Steps Required for Greater Glucose 
Transport by Isolated Skeletal Muscle 
 In male 9 mo-old Fisher 344 Brown Norway rats, 2-DG uptake by the 
insulin-stimulated soleus was significantly increased for the CR versus AL 
group.  
 There was no significant difference between CR and AL rats for soleus 
phosphorylation of the IR on Tyr1162/1163 at any time point, either with 
or without insulin.   
 Soleus tyrosine phosphorylation of IRS-1 was not significantly different 
between CR and AL rats regardless of insulin dose or time point.   
 IRS-1 associated PI3K in the soleus muscles was not significantly 
different for the CR versus AL group at any time point, either with or 
without insulin.   
 There was no significant effect of diet for either Akt Thr308 or Ser473 
phosphorylation in the soleus at any time point under basal conditions.  
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However, phosphorylation of Akt on both Thr308 and Ser473 was 
significantly increased for the CR versus AL group in muscles that were 
incubated with insulin for 50 minutes, but not for muscles incubated with 
insulin for 5 or 15 minutes. 
 
Study 3: In Vivo Assessment of the Effects of Calorie Restriction on Insulin-
stimulated Glucose Uptake and the Insulin Signaling Pathway in Multiple Skeletal 
Muscles 
 Whole body insulin sensitivity measured by glucose infusion rate during a 
euglycemic-hyperinsulinemic clamp was greater for CR versus AL rats 
that were studied with similar plasma insulin concentrations. 
 There was increased 2-DG uptake of the epitrochlearis, gastrocnemius, 
and tibialis anterior for insulin-stimulated CR versus AL rats and no 
significant difference between diet groups for 2-DG uptake of the 
plantaris, adductor longus, and soleus.  
 Phosphorylation of IR was not different between insulin-stimulated AL 
and CR rats for any of the muscles studied.  
 The most consistent effect of CR compared to AL was a robust increase in 
insulin-stimulated Akt phosphorylation found at both the Thr308 and 
Ser473 sites in the epitrochlearis, gastrocnemius, tibilais anterior, and 
soleus muscles.  
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 Akt Ser473 phosphorylation was increased for CR versus AL rats in the 
plantaris muscle, and there was a strong statistically non-significant trend 
(P=0.07) for an increase at Akt Thr308.  
 Only the adductor longus did not significantly differ between AL and CR 
for Akt phosphorylation at either the Thr308 or the Ser473 site.  
 AS160 (Thr642 and Ser588) phosphorylation was greater for CR versus 
AL in the insulin-stimulated epitrochlearis and tibialis anterior.  
 AS160 phosphorylation at Thr642, but not at S588, was greater for CR 
versus AL rats in the insulin-stimulated soleus muscle, and the plantaris 
had a statistically non-significant trend to increase at Ser588 (P=0.06) 
without a diet effect at Thr642.  
 There was no evidence for an increased AS160 phosphorylation in the 
gastrocnemius or adductor longus.  
 Filamin C phosphorylation on Ser2213 was greater for CR versus AL rats 
only in the insulin-stimulated plantaris muscle. 
 
Insights from Integrating the Results of Studies 1 to 3 
The studies in this dissertation investigated the mechanisms for calorie restriction 
(CR) effects on insulin-simulated glucose uptake in skeletal muscle using rats of different 
ages (9 or 24 mo-old) and using different experimental models for measuring glucose 
uptake (ex vivo or in vivo).  Together these studies offer new insights into possible 
mechanisms for CR-related benefits on insulin sensitivity in muscle.  This discussion will 
sequentially address the specific results for the insulin signaling pathway and then 
comment on the functional outcome of glucose uptake, with ideas for future research 
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included for each topic.  Table 6.1 summarizes the experimental design and results for the 
study by Sharma et al. and the studies from this dissertation. The following section 




Table 6.1 Summary of experimental design and results for study by Sharma et al. 
(24) and Studies 1 to 3 from dissertation.   
 
 Sharma et al.  
(24) 
Study 1 Study 2 Study 3 
Model Used for 
Insulin Exposure 
Ex Vivo Ex Vivo Ex Vivo In Vivo 
Age of Rats 9 mo-old 24 mo-old 9 mo-old 9 mo-old 
Muscles Studied E & S E & S S E, S, G ,T, P & A  
Insulin-stimulated  
pY-IR 




not measured not measured ↔ S not measured 
Insulin-stimulated  
IRS1-PI3K 
↔ E    ↔ S not measured ↔ S not measured 
Insulin-stimulated  
pAkt 




↑ E   ↔ S ↔ E   ↔ S not measured ↑ (E, S, T & P);  
↔ (G & A) 
Insulin-stimulated  
2DG Uptake 
↑ E     ↑ S ↑ E    ↑ S ↑ S ↑ (E, G & T);  
↔ (S, P & A) 
 
 
KEY:  E = Epitrochlearis; S=Soleus; G=Gastrocnemius; T=Tibialis Anterior; 
P=Plantaris; A=Adductor Longus; ↑ = CR significantly greater than AL for 






Table 6.2 Results of 2-way ANOVA showing main effects of insulin and diet and 
post-hoc analysis for Study 1.  
 
 Main Effect of 
Insulin 
Main Effect of 
Diet 
Post-hoc AL vs. 
CR with no 
insulin 
Post-hoc AL vs. 




EPI: P < 0.05 
SOL:P < 0.001 
 
EPI: P = 0.384 
SOL:P = 0.311 
EPI: P = 1.00  
SOL:P = 1.00  




EPI: P < 0.001 
SOL: P < 0.001 
 
EPI: P < 0.001 
SOL: P < 0.001 
EPI: P = 1.00   
SOL: P = 1.00  
EPI: P< 0.001  
SOL: P< 0.001  
Insulin-stimulated 
pAkt S473 
EPI: P < 0.001 
SOL: P < 0.001 
 
EPI: P < 0.001 
SOL: P < 0.001 
EPI: P = 1.00  
SOL: P = 1.0 
EPI: P< 0.001  
SOL: P< 0.001 
Insulin-stimulated 
pAS160 T642 
EPI: P < 0.001 
SOL: P < 0.001 
 
EPI: P =0.198 
SOL: P = 0.388 
EPI: P = 1.00  
SOL:P = 0.699 
EPI: P = 0.341  
SOL:P = 1.00 
Insulin-stimulated 
pAS160 S588 
EPI: P < 0.01 
SOL: P < 0.001 
 
EPI: P = 0.310 
SOL: P = 0.051 
EPI: P = 1.00  
SOL:P = 1.00 
EPI: P = 0.850  
SOL:P = 0.203 
Insulin-stimulated 
pTBC1D1 T596 
EPI: P = 0.108 
SOL: P = 0.194 
 
EPI: P = 0.301 
SOL: P = 0.979 
EPI: N/A  
SOL:N/A 




EPI: P < 0.005 
SOL: P < 0.001
 
EPI: P < 0.05 
SOL: P < 0.001 
EPI: P = 1.00  
SOL:P = 1.00 
EPI: P = 0.055  
SOL:P < 0.001 
Insulin-stimulated 
2DG Uptake 
EPI: P < 0.005 
SOL: P < 0.001 
 
EPI: P < 0.01 
SOL: P < 0.01 
EPI: P = 1.00  
SOL:P = 1.00 
EPI: P < 0.05 
SOL:P < 0.05 
 
 
KEY:  Epi = Epitrochlearis; Sol=Soleus; N/A= Not applicable; Post-hoc AL vs. CR 
refers to the results of the post-hoc Bonferroni test for each incubation for insulin 
exposure during ex vivo incubation (with no insulin or with 1.2 nM insulin).  P value 




CR Effects on Insulin Signaling Proximal to Akt 
Insulin receptor phosphorylation did not increase with CR versus AL regardless 
of age (9 or 24 months) or model (ex vivo or in vivo).  Muscles from CR versus AL rats 
did not differ significantly for IRTyr1162/1163 phosphorylation, IRS-1Tyr phosphorylation, or 
IRS-1-associated PI3K activity, when tested at multiple time points (5, 15 and 50 
minutes).  These results suggest that the CR-related amplification of post-receptor 
signaling and glucose uptake in muscle stimulated by a physiologic insulin dose do not 
appear to be attributable to greater activation of insulin signaling proximal to Akt.  
Supporting the results of Study 2 of this dissertation, previously published research 
indicated a lack of a CR effect on IRS1-, IRS2, or phosphotyrosine PI3K was reported 
with 3 nM insulin in the epitrochlearis (25).  Sharma et al.  (24) observed no CR effect on 
PI3K activity together with no evidence for a CR effect on atypical PKC activity.  The 
lack of any change in atypical PKC activity with CR, a step that is dependent on the 
proximal signaling events that also regulate Akt (including insulin receptor and IRS-1 
tyrosine phosphorylation and IRS-1-PI3K activity) is consistent with a lack of a general 
increase in proximal signaling with CR, and it supports the idea of CR does not uniformly 
enhance all signaling events that are modulated by insulin via activation of PI3K activity. 
Nonetheless, it remains possible that the lack of a statistically detectable CR 
effect on proximal signaling concomitant with a consistently significant CR effect on Akt 
could potentially be related to differences in the technical precision of the methods used 
to quantify the different insulin signaling steps.  The dynamic range was smaller and the 
variability was greater for proximal signaling markers versus Akt signaling.  It is possible 
that the lack of a statistically detectable CR effect of proximal signaling steps in this 
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study was due to insufficient sample size and statistical power.  Only 3 time points were 
assessed and a difference may have been missed at an intermediate time point that was 
not studied.  However, it is important to note that significant insulin effects were detected 
for proximal signaling in Studies 1 (Table 6.2 includes the P-values for insulin main 
effects based on 2-Way ANOVA) and 2 (Figures 4.2 to 4.5) of this dissertation, 
indicating that there was sufficient technical precision and statistical power to discern the 
effects of a physiologic insulin dose on each of the proximal insulin signaling steps 
measured for ex vivo epitrochlearis and soleus muscles.  In addition, a recently published 
study from our group also found significant effects of insulin infusion compared to basal 
conditions (without insulin infusion) on insulin receptor tyrosine phosphorylation in 
multiple muscles studied under hyperinsulinemic clamp conditions identical to those used 
in Study 3 (115).  However, it remains possible that a small and/or variable CR-related 
increase occurred for one or more proximal insulin signaling step, but was missed 
because it was below the limit of detection of the technical approaches that were used.  
 
CR Effects on Activation of Akt  
Akt phosphorylation was greater for CR versus AL for each age (9 versus 24 
months) and for each model (ex vivo and in vivo).  Thus, in striking contrast to the lack 
of detectable CR effects on insulin signaling at steps proximal to Akt, there was a 
substantial and significant CR effect on Akt phosphorylation in all of the studies of the 
dissertation.  The simplest interpretation of the results of this dissertation is that the 
increase in Akt phosphorylation does not appear to be attributable to CR effects on key 
upstream signaling steps.   What are some possible mechanisms whereby CR may be 
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affecting insulin sensitivity by distinctly acting on the level of Akt signaling without the 
need for enhanced signaling at proximal steps?   
One possible explanation for increased Akt phosphorylation for CR versus AL 
could be due to a CR effect that results in attenuated action of the relevant protein 
phosphatases that are responsible for dephosphorylation of Akt.  Several studies have 
demonstrated that protein phosphatase 2A (PP2A) can regulate kinase activity such as 
Akt phosphorylation (143-146).  However, CR was reported to have no effects on Akt 
associated PP2A in the epitrochlearis and soleus muscles from 9 mo-old rats (24).  PP2A 
has also been shown to be regulated by tyrosine 307 phosphorylation (147-149) and 
leucine 309 methylation (150-153), but the effects of CR on these post-translational 
modifications is unknown.  PP2A is one of several phosphatases that regulate protein 
serine/threonine phosphorylation in skeletal muscle (154-158), and it is possible that 
other phosphatases (PP1, PP2B, PP2C) may be altered with CR.  
A second possibility is that there are other post-translational modifications (e.g. 
acetylation) of Akt are influenced by CR and modulate Akt activation. The Sirt1 
deacetylase has been reported to promote localization and activation of Akt (159, 160) 
and represents a mechanism that may play a role in the increase in Akt activation with 
CR.  CR was reported to increase Sirt1 deacetylase activity in skeletal muscle of mice 
(117), but CR effects on Akt acetylation are currently unknown. 
A third possibility is that regulatory proteins that are known to bind to and 
modulate Akt phosphorylation may be altered by CR.  Heat-shock protein 90 (HSP90) 
has been reported to oppose dephosphorylation of Akt by protein phosphatases (161).  
Sharma et al (24) studied the effect of CR on HSP90 and found that CR increased the 
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association of HSP90 and Akt with insulin stimulation in the epitrochlearis muscle.  
However, there was no evidence for increase Akt and HSP90 association in the soleus 
muscle suggesting that different mechanisms may account for greater Akt 
phosphorylation in the soleus of CR rats.  At least in the epitrochlearis, the CR mediated 
increase in HSP90-Akt binding may be significant for the CR-enhancement of Akt 
phosphorylation.  Specific HSP90 inhibitors (162, 163) could be used to determine if 
HSP90 is playing a significant role in the CR effect on Akt phosphorylation that is 
routinely seen in skeletal muscle.  Several other proteins have been reported to favor 
either greater Akt phosphorylation [e.g. PHLDB1(118), ClipR-59 (119)] or less Akt 
phosphorylation [e.g CTMP (120), TRB3 (121)].  Co-immunoprecipation of Akt and 
these various Akt-binding proteins in multiple muscles from CR compared to AL rats 
would provide clues on how CR acts to enhance Akt phosphorylation.  It seems possible 
that CR actions on Akt–binding proteins may also influence the localization of Akt and 
influence the spatial organization to regulate Akt’s co-localization with specific Akt 
substrates.  To further probe this idea, specific inhibitors or genetic approaches to 
manipulate the expression of these candidate proteins would be useful.  For example, 
siRNA that is specific to each candidate protein could be transfected into the skeletal 
muscle of CR and AL rats to determine if CR enhanced Akt association with Akt-binding 
proteins are important for the CR-mediated increase in Akt phosphorylation. Similarly, 
altering binding of Akt to Akt binding proteins by mutations on key binding amino acids 
would be an additional method to determine the significance of their association.  
Alternatively, overexpression experiments could also shed light on the importance of 
these Akt-binding proteins.  Electrotransfection experiments could be used to up-regulate 
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plasmid DNA of interest using in vivo gene delivery to skeletal muscle.  These 
approaches would provide important information on the regulation of Akt 
phosphorylation by Akt binding proteins. 
 
CR Effects on Phosphorylation of Akt Substrates 
Akt, the insulin signaling protein that has been found to be most consistently 
altered in response to CR, is a kinase that phosphorylates downstream substrates that are 
necessary for the CR-mediated enhancement of insulin stimulated glucose uptake in 
skeletal muscle.  AS160 is the most studied Akt substrate that has been implicated in 
regulating glucose transport.  AS160 was evaluated in the soleus for Studies 1 and 3, but 
was not studied for the soleus ex vivo in 9 mo-old rats.  However, this information is 
available from an earlier study by Sharma et al. (24) (see Table 6.1) that was a precursor 
and template for the design of the 3 studies in this dissertation (with regard to the strain 
and sex of the rats, the specific CR protocol used, the insulin dose evaluated, and many of 
the key measurements that were made).  Therefore, if we consider the results of Studies 1 
and 3 together with the results of Sharma et al. (24) for AS160, it is apparent that CR 
does not increase AS160 phosphorylation in the soleus ex vivo in either 9 or 24 mo-old 
rats, even though CR is characterized by greater insulin-stimulated glucose uptake in the 
soleus at both ages.  However, data from Study 3 indicate that CR does result in greater 
insulin-stimulated AS160 phosphorylation in the soleus when measured in vivo in the 
absence of a CR-related increase in insulin-stimulated glucose uptake. Taken together, 
the results for the soleus demonstrate that greater AS160 phosphorylation is not 




AS160 phosphorylation in the ex vivo epitrochlearis was greater for CR versus 
AL in 9 mo-old rats, but there was no evidence of a CR-related increase in AS160 
phosphorylation in the ex vivo epitrochlearis of 24 mo-old rats.   It is unclear what links 
elevated Akt phosphorylation to enhanced glucose uptake in old rats, but the lack of 
greater AS160 phosphorylation in the epitrochlearis of old CR rats suggests that alternate 
Akt substrates may be enhanced and account for greater glucose uptake with CR.  It 
would be worthwhile to probe CR effects on new Akt substrates to reveal potential 
mechanisms that may explain the CR improved glucose uptake in 24 mo-old rats. 
CDP138, an Akt substrate, was reported to regulate GLUT4 insertion into the plasma 
membrane (164) and may be relevant for the CR effect on insulin-stimulated glucose 
uptake in the epitrochlearis and other skeletal muscles.  
This dissertation also evaluated the effect of CR on in vivo insulin induced 
activation of AS160 in the epitrochlearis. When the CR effects on AS160 
phosphorylation were probed in vivo there was a significant increase in the epitrochlearis 
for CR versus AL in 9mo-old rats.  Comparing the AS160 phosphorylation for ex vivo 
and in vivo, the data provides evidence that AS160 phosphorylation is responsive to the 
effects of CR in the epitrochlearis.  Three additional predominantly fast-twitch muscles 
were studied in 9 mo-old CR and AL rats, and there was evidence for a CR-related 
increase in AS160 phosphorylation in the tibialis anterior and plantaris muscles but no 
effect of CR on AS160 phosphorylation in the gastrocnemius.  The lack of a uniform 
effect of CR on AS160 phosphorylation in the 4 fast-twitch muscles that were studied in 
vivo is not attributable to differences in these muscles for CR effects on Akt 
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phosphorylation, because all 4 of the fast-twitch muscles responded to CR with greater 
Akt phosphorylation.  
Filamin C is a protein that was recently discovered in research using cultured cells 
to be regulated by Akt-dependent phosphorylation in response to insulin (76).  Prior to 
the completion of this dissertation, there was no published research on insulin’s effects on 
the phosphorylation of filamin C in skeletal muscle tissue (i.e., only in cultured cells).  
This dissertation demonstrated phosphorylation of filamin C in insulin-stimulated 
muscles from 24 mo-old rats in Study 1 to be responsive to CR.  Filamin C increased 
with CR in Study 1 in 24 mo-old rats in epitrochlearis and soleus muscles.  However, in 
Study 3, filamin C only increased in 1 out of 6 muscles studies in vivo, and glucose 
uptake was not enhanced by CR for this muscle (the plantaris), indicating that greater 
filamin C phosphorylation does not account for CR effects on muscle glucose uptake in 
vivo.  Although these results argue against greater phosphorylation of filamin C being 
essential for CR effects on in vivo glucose uptake by skeletal muscle, it remains possible 
that filamin C is important for insulin-stimulated glucose uptake in skeletal muscle.  
Therefore, it would be valuable to perform experiments with serine to alanine mutations 
on the Ser2213 site to test if the ability to phosphorylate this site is important for insulin-
stimulated glucose uptake. 
CR does not uniformly enhance phosphorylation of all Akt substrates and this 
may be due to localization in certain subcellular regions. It is possible that the inability to 
recognize a CR effect on particular signaling proteins in skeletal muscle may be the result 
of measuring the signaling proteins in whole muscle lysates.  Subcellular localization of 
proteins is crucial for their functional capacity, and localization of insulin signaling 
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proteins to the plasma membrane is necessary for their ability to regulate the GLUT4 
transporter and glucose transport (165).  Therefore, measuring specialized pools of key 
signaling proteins may reveal CR effects on insulin-stimulated samples that previously 
were masked by measuring whole cell lysates. It is still not entirely clear how Akt 
substrates implicated in GLUT4 translocation function with CR.  
  
CR Effects on Glucose Uptake 
The effects of CR on insulin signaling were examined to probe the potential 
mechanism of the CR-enhancement of insulin-stimulated glucose uptake in skeletal 
muscle.  Glucose uptake is a rate-limiting step in skeletal muscle glucose metabolism and 
represents a key regulatory step improved by CR.  Thus, insulin-stimulated glucose 
uptake was the most significant functional endpoint measurement that was studied in this 
dissertation.  
Studies 1 and 3 included data for the predominantly fast-twitch epitrochlearis 
muscle, but the dissertation did not include results for ex vivo epitrochlearis muscles 
from 9 mo-old rats.  However, this information is available from the earlier study by 
Sharma et al. (24).  Therefore, the next section of the discussion will consider the results 
of Studies 1 and 3 together with those of Sharma et al. for the epitrochlearis.   2DG 
uptake increased with CR versus AL in the epitrochlearis regardless of age (9 versus 24 
mo-old) or model (ex vivo or in vivo).   Thus, there was a consistent CR effect on glucose 
uptake by the epitrochlearis in every model in this dissertation.   It might be suspected 
that because the epitrochlearis is a predominantly fast-twitch muscle, that it may also be 
true that other predominantly fast-twitch muscles are also very responsive to the CR-
mediate increase in insulin-stimulated glucose uptake.  However, it would be unwise to 
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make this generalization based only on the results of a single muscle.  The epitrochlearis 
along with three additional fast-twitch muscles (gastrocnemius, tibialis anterior and 
plantaris) were evaluated in Study 3.  Although these muscles were not studied under ex 
vivo conditions because their large sizes makes them unsuitable for this procedure, it is 
possible to compare their results with the epitrochlearis in vivo data to evaluate the 
possibility of identifying fiber-type related patterns for the effects of CR.  There was a 
significant CR effect on 3 of 4 predominantly fast-twitch muscle.  The plantaris was the 
only predominantly fast-twitch muscle in which there was not a CR effect on insulin-
stimulated glucose uptake.  Because the MHC isoform makeup of the plantaris is similar 
to the other predominantly fast-twitch muscles in this study, fiber type composition does 
not seem to account for the lack of a CR-mediated increase in insulin-stimulated glucose 
uptake in the plantaris.  It remains to be determined why CR had no effect on glucose 
uptake in the plantaris.   The results of previous studies from a single muscle (e.g., the 
epitrochlearis) are often used to represent all predominantly fast-twitch muscles (3, 10, 
21, 25, 85-87).  The current results demonstrated that most, but not all (3 of 4) of the 
predominantly fast-twitch muscles studied were responsive to a calorie restriction-
induced elevation in insulin-stimulated glucose uptake.  Based on available evidence in 
this dissertation, there is not an obvious explanation to why there was not was not 
significant increase in insulin-stimulated glucose uptake for CR versus AL in the 
plantaris.    
Enhanced insulin-stimulated glucose uptake with CR was observed in the 
epitrochlearis using both ex vivo and in vivo models. Sharma et al. reported a 61% 
increase in insulin-stimulated glucose uptake for CR versus AL. Similarly, in this study 
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there was a 71% increase in insulin-stimulated glucose uptake for CR versus AL in the 
epitrochlearis.  Studying both models in the epitrochlearis allowed the comparison of 
factors intrinsic to the muscle (ex vivo) versus the combination of intrinsic and extrinsic 
factors (in vivo) that contributed to CR effects on the muscle. The fold increase ex vivo 
(~1.6-fold) was roughly similar to the fold increase in vivo (~1.7-fold), suggesting that 
the mechanism for the CR-enhancement on glucose uptake in the epitrochlearis is, at least 
in large part, intrinsic to the muscle because most of the CR effect on insulin-stimulated 
glucose appears to be present even in the absence of systemic factors.  The results from 
the ex vivo condition also show that the effect of CR on insulin-stimulated glucose 
uptake in skeletal muscle persists in the presence of systemic factors extrinsic to the 
epitrochlearis.  This shows that the benefit of CR by increasing insulin-stimulated 
glucose uptake is preserved in a more physiologically relevant environment and likely 
critical to the general benefits of CR on whole organisms.   
Glucose uptake measured ex vivo in the soleus increased with CR versus AL for 
both 9 mo-old (Study 2) and 24 mo-old (Study 1) rats, but there was no significant CR-
related increase when 2DG uptake was measured in vivo in the soleus.  The difference for 
in vivo versus ex vivo glucose uptake by the soleus of 9 mo-old rats suggests that 
systemic factors may have eliminated the CR effects observed in isolated soleus muscles. 
It is possible that differences for the effect of CR on soleus glucose uptake measured in 
vivo versus ex vivo are related to differences in measurement methods used for the in 
vivo versus ex vivo experiments.  Ex vivo glucose uptake measurement for Studies 1 and 
2 and for the experiment by Sharma et al. (24) used the standard assay procedures that 
result in quantifying the accumulation of both 2-DG and 2-DG-6-P as described 
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previously (110, 141).   In vivo glucose uptake was measured in Study 3 using the 
standard assay procedures that result in the accumulation of only 2-DG-6-P as described 
previously (126-128). Another possibility is that differences between the in vivo and ex 
vivo conditions (e.g., duration and concentration of insulin exposure; presence or absence 
of glucose when 2-DG uptake occurred) may have contributed to the differences with 
regard to CR effects on 2-DG uptake by the soleus measured in the two conditions.  It is 
not possible to recapitulate the ex vivo incubations (no glucose during 2-DG 
accumulation) during in vivo glucose uptake measurement, but it is feasible to mimic 
many of the conditions of the in vivo experiment (2 hr insulin exposure in the presence of 
glucose, with radiolabelled 2-DG included during the final 30 min of insulin exposure) 
for the ex vivo glucose uptake measurement.  It is also possible to measure both 2-DG 
and 2-DG-6-P accumulation as well as only 2-DG-6-P accumulation in the ex vivo 
muscles.  Insulin-stimulated soleus and epitrochlearis muscles from AL and CR rats 
would be studied using the conditions that simulated the in vivo conditions during the 
clamp.   After incubation, muscles would be divided and processed so that one portion 
could be used to quantify 2-DG-6-P alone and the other portion would be processed to 
quantify both 2DG-6-P and 2-DG.  If necessary, follow-up studies could then be 
performed to probe the specific roles of insulin concentration, insulin exposure time, and 
inclusion of glucose during the 2-DG uptake assay to account for differing effects of CR 
on glucose uptake results.   
 
Novel Insights and Perspectives from the Research in this Dissertation 
The most unique and important feature of the research  in this dissertation was 
probing the mechanisms of CR effects on insulin-stimulated glucose uptake by rat 
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skeletal muscles using multiple perspectives by exploring time-course effects, evaluating 
both ex vivo and in vivo models, and studying six different muscles.  This strategy 
provided the most complete representation of CR on skeletal muscle glucose metabolism 
to date by combining all of the individual assessments in Study 1 to 3.  
Overall, CR’s most consistent effect on signaling was for Akt phosphorylation, 
regardless of age or experimental model (in vivo or ex vivo).  From each perspective, Akt 
phosphorylation was enhanced with CR.  Without exception, insulin-stimulated Akt 
phosphorylation increased without any detectable change in proximal insulin signaling 
when insulin-stimulated glucose uptake was increased in any skeletal muscle for CR 
versus AL.  Taken together, these results provide evidence that strongly suggests that  
increased Akt phosphorylation is a key insulin signaling step that is important for the CR-
related increased insulin-stimulated glucose uptake.  It would be valuable for future 
experiments to focus on Akt signaling in order to establish causality of Akt 
phosphorylation on the CR-mediated increase in skeletal muscle insulin-stimulated 
glucose uptake.  
Studies 1 and 3 evaluated CR effects on both Akt and two of its substrates, AS160 
and filamin C in multiple muscles under both ex vivo and in vivo conditions.  The more 
consistent effect of CR on Akt than on its Akt substrates reveals the complexity of their 
relationship with each other.   It was clear that there was not a single uniform pattern for 
the activation of Akt substrates even though there was a consistent increase in Akt 
phosphorylation in almost every condition. This complex relationship between the CR 
effects on phosphorylation of Akt and Akt substrates may be related to CR effects on 
various regulatory factors, including altering the level of binding of proteins to Akt or to 
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the substrates, the actions of protein phosphatases, and/or the extent of co-localization of 
Akt and each of its substrate. 
The similarity for CR-related effects on ex vivo and in vivo glucose uptake for the 
epitrochlearis, but not the soleus, suggests a muscle-specific difference in susceptibility 
to the influence of systemic factors.  In vivo experimentation is advantageous because 
insulin-stimulated glucose uptake measurements are taken in a physiological context and 
includes the influence of usual-living insulin levels, blood flow, neural inputs, and blood 
chemokines that may influence CR’s effects on skeletal muscle.  It will be important that 
future experiments use in vivo models in combination with ex vivo experimentation. 
Conclusions made from ex vivo models provide a framework that should guide in vivo 
experimentation where effects can be quite distinct but more physiologically relevant.   
A striking result of this dissertation was the demonstration that skeletal muscles 
with similar fiber type profiles can have different responses to CR for effects on in vivo 
insulin signaling and glucose uptake. The most interesting example of this heterogeneity 
was the plantaris muscle.  The plantaris was the only predominantly fast-twitch muscle in 
which CR did not enhance in vivo insulin-stimulated glucose uptake.  It is evident that 
there is not a simple fiber-type pattern that uniformly predicts a CR-related increase for 
insulin-stimulated glucose uptake.  Akt and AS160 phosphorylation increased for CR 
versus AL in the plantaris, but there was no increase in insulin-stimulated glucose uptake.  
These observations support the conclusion that the CR-induced enhancement of insulin-
stimulated activation of Akt may be necessary, but not sufficient for the CR-induced 
increase in insulin-stimulated glucose uptake.  In vivo filamin C phosphorylation was 
increased for CR versus AL in the plantaris muscle which suggests that filamin C is 
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neither necessary nor sufficient for insulin-stimulated glucose uptake.  The results of 
Study 1 indicated that filamin C may be important for the CR related increase in insulin-
stimulated glucose uptake in ex vivo muscles from 24 mo-old rats.  However, filamin C 
appears to be less important in 9 mo-old rats (versus 24 mo-old rats) and in vivo (versus 
ex vivo) for the CR related increase in insulin-stimulated glucose uptake.    
The novel results of the research in this dissertation revealed that there are 
similarities and differences among different skeletal muscles of similar fiber type 
profiles, suggesting a complex interplay between each muscle’s intrinsic properties and 
the extrinsic systemic factors, with the interaction between the intrinsic and extrinsic 
features accounting for the CR effects on each skeletal muscle.  The effects of CR on 
insulin-stimulated glucose uptake in skeletal muscle are not simply attributable to the 
fiber type composition as might have been predicted based on earlier studies.  The results 
of Study 3 confirm that greater whole body insulin sensitivity, at least in part, is 
attributable to substantial CR effects on in vivo insulin-stimulated glucose uptake by 
skeletal muscle.  However, fully understanding the effects of CR on whole body insulin 
sensitivity will require additional research to elucidate the specific mechanisms that 
modulate the metabolic functions of multiple diverse skeletal muscles.  Ultimately, the 
influence of CR across of the muscles and other tissues can be summed to create a mosaic 
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